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ABSTRACT 
Fertility preservation is considered a great hope to people suffering from infertility as a 
consequence of developmental or genetic cause, a disease itself or its treatments sequelae. 
In vitro models are fundamental to enrich our knowledge about human germ cell 
development and its regulation, to generate and screen new therapeutic measures and might 
provide a tool that can be transferred to clinical use to treat infertility. There are, in 
principle, two strategies to start an in vitro fertility preservation protocol in male humans. 
First the in vitro generation of germ cells by differentiating human pluripotent stem cells and 
second the maturation and differentiation of human spermatogonia stem cells into more 
advanced stage of germ cells. However, both strategies are not suitable to be used in the clinic 
since the robust protocols for differentiation are not available. Additionally, reproducibility of 
the results between different laboratories is a big challenge faced by researchers working in 
the field. 
Therefore, we focused in this thesis on these two strategies aiming to improve both models 
to reduce variability and improve reproducibility. In the first study, we addressed the 
variability occurring among hES cell lines when used for human germ cell differentiation. 
We aimed to find a suitable culture condition allowing a robust starting point for our 
cultures by using LN521 as a culture matrix for hES cells before using them in protocols of 
differentiation. Moreover, we investigated the only robust working system in rodents and 
aimed to translate this to the situation in humans by using normal fetal gonadal tissues as 
well as actual patient materials to investigate the potential use of these systems to mature 
human germ cells in vitro.  
We found that LN521 has positive effects on hES cells growth and maintenance of their 
pluripotency characteristics with no influence on gonadal cells related genes expression. 
Furthermore, we showed that LN521 homogenized the gene expression variation among the 
five cell lines used in the study. In regard to in vitro germ cells maturation from 
spermatogonial stem cells, production of elongated spermatids was achieved when air liquid 
interphase organ culture method was used to cultivate mouse testicular tissues in vitro. A 
supplementation of 10% knockout serum replacement is shown to have positive effects on 
tubular maturation, germ cell proliferation and differentiation. We showed that organ 
culture method could be used to culture and study human first trimester gonads somatic 
cells in vitro as demonstrated by their ability to produce hormones in a manner similar to 
what is described for in vivo situation. In addition, differences in somatic cells functions in 
testicular tissues from different patient groups exposed to hematological and oncological 
treatments could be illustrated by culturing these tissues in vitro by using organ culture 
method. 
Culturing human embryonic stem cells on LN521 could be a step forward towards future 
applications of human embryonic stem cells in regenerative medicine by providing more 
predictable and controllable system to assess the behavior of human embryonic stem cells 
when used in different protocols for differentiation. This would be the basis for future 
approaches to generate more defined in vitro protocols for differentiation of human 
pluripotent stem cells towards germ cells. On the other hand, organ culture method could be 
a useful tool to study the process of human germ cells development and to screen the effect 
of different substances on human gonadal cell development and function. Moreover, it can 
be used as quality assessment tool of cryopreserved testicular tissues, from patients exposed 
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1 INTRODUCTION 
Fertility preservation for patients who are not able to produce sperm, because of genetic cause 
or as a consequence of treatment received, is a challenge. No clinical option available till now 
to preserve the fertility of such a group. In vitro generation and/or maturation of germ cells 
are considered a promising method in this regard. There are, in principle, two strategies to 
start an in vitro fertility preservation protocol in humans: the use of human pluripotent stem 
cells and the use of male germ cells as a starting point. To understand the work done in this 
thesis, the following chapters will address the basic knowledge as well as some clinical topics 
related to in vitro models for fertility preservation. 
1.1 HUMAN STEM CELLS 
1.1.1 Embryogenesis 
Embryogenesis is the process by which human development begins. It includes all events 
from the union of the sperm and the oocyte to form a zygote to the establishment of the 
fetus[1]. The creation of a zygote takes place in the ampulla of the oviduct where one sperm 
penetrates through the zona pellucida of the oocyte. The formed zygote undergoes mitotic 
cellular division with no significant growth happening at this stage, while it is propelled 
towards the uterus by the cilia in the oviduct [1]. The eight-cell stage zygote is called 
blastomere and continues to divide further. During this process, the blastomere forms a 
compact sphere. The cells within the sphere interact with each other through gap junction [2]. 
The conceptus develops further to form a 16-cell morula. At this stage, the cells have 
differentiated and formed two cell layers; the inner layer (non-polarized) and the outer layer 
(polarized) [1, 3]. 
During the next step of conceptus development, a fluid filled cavity called blastocoele is 
formed and the conceptus is called blastocyst at this stage. The non-polarized cells give rise 
to the inner cell mass (ICM) which develop into all parts of the embryo and the extra-
embryonic membranes including amnion, yolk sac and allantois [1, 4]. The polarized cells 
form a trophoblast layer which will form the chorion, the embryonic part of the placenta. The 
placenta consists of the chorion and the decidua (the maternal part). It provides the 
developing embryo with nutrition and disposes of waste. In addition, the placenta helps in 
blocking the immune rejection of the conceptus by the mother. Upon entry to the uterus, 
about 5-6 days after fertilization the blastocyst starts to produce plasmin which facilitates the 
process of the hatching into the uterus wall by degradation of the zona pellucida. At this 
stage, the ICM has formed a bilaminar disc that consists of hypoblast and epiblast. The 
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hypoblast develops into the extra-embryonic endoderm and the embryonic epiblast. The 
amniotic endoderm produces the amniotic fluid and contains and protects the embryo. The 
embryonic epiblast develops into three embryonic germ layers as well as germline cells by a 
process called gastrulation, which will be followed by the organ formation stage 
(organogenesis) [1, 4]. The embryonic ectoderm will form, for example, the nervous system, 
the dermis and lenses of the eyes. The mesoderm will develop into, for example, the skeleton, 
the skeletal muscles and the heart. The endoderm will give rise to, for example, the stomach, 
the liver and the epithelial part of the trachea [1, 4].  
1.1.2 Pluripotent stem (PS) cells  
As a common feature, stem cells are uncommitted cells that have two main characteristics. 
First is their ability for self-renewal. Second is their ability to differentiate to a diverse range 
of more specialized cells in vivo and in vitro. A stem cell remains uncommitted unless it gets 
a signal for differentiation into more specialized cell type. There are various stem cell types, 
shown different grades of potencies, identified in human body in embryonic, fetal and adult 
tissues. In addition to stem cells occurring in vivo, it has been possible to produce stem cells 
from somatic cells in vitro, called induced pluripotent stem cells (iPS cells), which share 
similarities with human embryonic stem (hES) cells. Overall, stem cells can be classified 
according to their differentiation potentials into: totipotent, pluripotent, multipotent and 
unipotent. Totipotent stem cells have full potential for differentiation and they can 
differentiate to embryonic three germ layers and extraembryonic tissues as well 
(trophectoderm). The zygote and the early stages of the embryo are the only totipotent cells 
[5]. Pluripotent stem cells are able to self-renew and differentiate into the three germ layers as 
well as the germline cells. Multipotent and unipotent stem cells lineages are restricted cells 
found within specialized tissues and they are also called adult stem cells. They have the 
ability to differentiate into different specialized cell types. In the adult body they can be found 
in hair, skin, bone marrow, central nervous system and the testis. 





PS cells are able to self-renew and differentiate into the three germ layers as well as the 
germline cells. The cells of the ICM at blastocyst stage are characterized as pluripotent. They 
differ from the totipotent cells because they cannot give rise to the trophoblast and thus they 
are unable to differentiate to all the cells of the conceptus. The ICM cells can be derived from 
the blastocyst and cultured in vitro as pluripotent embryonic stem cells (ES cells) [6, 7]. The 
main characteristics of PS cells are their unlimited self-renewal capacity and their ability to 
differentiate to diverse cell types of the three germ layers, as well as into germline cells 
(Figure1). These characteristics make PS cells promising candidates for regenerative 
medicine in studying and treating disorders involving loss of specific cell types or tissues for 
example diabetes, Parkinson´s disease and infertility. In addition, these cells can be utilized 
for studying developmental processes and also for drug screening. PS cells include hES cells 
Figure 1. Human pluripotent stem cells sources. Human pluripotent stem (hPS) cells include hES cells 
and hiPS cells. hES cells are derived from human embryos at blastocyst stage from the ICM. hiPS 
cells are derived by induction of human somatic cells by specific reprogramming factors. hPS cells 
have the potential to renew themselves and to differentiate to ectodermal, endodermal, mesodermal 
and germ cells. 
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and human iPS cells. Both types will be addressed in the following chapters with a special 
focus on fertility preservation. 
1.1.2.1 Human embryonic stem cells (hES cells) 
HES cells are pluripotent stem cells derived from supernumerary blastocysts (5-6 days after 
fertilization) donated from patients who underwent in vitro fertilization (IVF) treatment. The 
derivation of hES cell lines is achieved by isolating ICM of a blastocyst stage embryo and 
placing it into culture conditions which support undifferentiated cell proliferation [8]. There 
are several methods for derivation of hES cells: immunosurgical, partial or whole embryo 
culture and surgical isolation of the region containing the ICM with an ultra-fine glass 
pipette. The choice of the method depends on the quality and size of the embryo. The 
immunosurgical method is associated with the risk of hES cells contamination with animal 
pathogens[9]. Partial or whole embryo culture, in which the blastocyst is seeded directly on a 
STO feeder layer without its zona pellucida, helps in overcome this problem. However, it is 
observed that in this method the trophectodermal overgrowth hinder the expansion of the 
ICM. This problem of trophectodeermal overgrowth is alleviated by the surgical isolation of 
the region containing the ICM with an ultra-fine glass pipette. The efficiency of the surgical 
isolation is comparable to that of the immunosurgical isolation [10]. To avoid the destruction 
of the whole embryo which creates a big ethical debate, hES cells can be derived from a 
single blastomere of a morula (8-10 cell stage embryo) with no harm or destruction of the 
embryo [11, 12]. 
1.1.2.2 Human induced pluripotent stem cells (hiPS cells) 
The principle behind the creation of induced pluripotent stem (iPS) cells is induction of 
somatic cells by defined factors. The first iPS cell line was produced in 2006 when Takahashi 
group reprogrammed mouse embryonic and adult fibroblast into iPS cells by forced 
expression of four transcription factors including: Core transcription factor POU class 5 
homeobox 1 (Pou5f1), SRY (sex determining region Y)-box (Sox2), Krueppel-like factor 4 
(Klf4), and v-Myc myelocytomatosis avian viral oncogene homolog (c-Myc) [13]. A year 
later, the first hiPS cells line was produced using the same transcription factors [14]. After 
that, many studies were published demonstrating the use of different transcription factors to 
produce iPS cell lines or to aim for optimization of generation of iPS cells from different 
types of somatic cells [15]. Initially, iPS cells were produced by using retroviral or lentiviral 
for induction and were derived and cultured on mouse feeders. Followed this, many 
approaches were reported to have improved the induction process as well as the derivation 
and culture methods aiming for higher efficiency integration-free and feeder-free conditions. 
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As a step forward to integration-free reprogramming, non-integrating viruses such as Sendai 
virus [16], non-integrating episomal plasmids [17, 18] as well as direct transfection with 
mRNA or proteins were used [19]. In addition, mouse feeders were replaced by feeder-free 
methods using matrices such as Matrigel and vitronectin. Despite the great efforts done by 
researchers in the field aiming for improvement of the reprogramming methods to make it 
more suitable for clinical use, it seems that an integration-free method with feeder-free and 
defined xeno-free condition for iPS cells production is still a challenge. 
1.1.3 Characterization of human embryonic stem cells 
The characteristic morphology of hES cells is a high nucleus to cytoplasmic ratio and 
prominent nucleoli [8]. HES cells form relatively flat compact colonies with distinct cell 
borders [8]. They can be cultured for extended period of time and they retain their 
pluripotency and normal karyotype. To assess pluripotency of hPS cells, which include hES 
cells and hiPS cells, there are sets of cell surface markers and transcription factors to be 
expressed by these cells. In addition, the capacity for differentiation in vitro and in vivo 
should be used also [20]. HPS cells express standard cell surface markers including: stage-
specific embryonic antigen 3 (SSEA3), stage specific embryonic antigen 4 (SSEA4), tumor-
related antigen (TRA)-1-60, tumor-related antigen (TRA)-1-80 and alkaline phosphatase 
(ALP) [8]. Core transcription factor POU class 5 homeobox 1 (POU5F1), Nanog homeobox 
(NANOG) and SRY (sex determining region Y)-box (SOX) 2 are required for these cells´ 
pluripotency and self-renewal and they are used in the characterization of hPS cells routinely 
[21]. The capacity of hPS cells to differentiate towards the three germ layers is assessed by in 
vitro and in vivo assays. By injection of hPS cells into severe combined immunodeficient 
(SCID) mice, in vivo hPS cells form teratomas which contain ectodermal, mesodermal and 
endodermal origin [8]. In vitro, the assessment is done by formation of cell aggregation called 
embryoid bodies (EBs) which contains spontaneously differentiated cells from all three germ 
layers [22]. Differentiation towards germ cells has been reported. However, the 
reproducibility of these protocols is rather low and new strategies to improve them by 
providing a robust starting point will be addressed and discussed in paper I and the following 
chapters. 
1.1.4 Culture of human embryonic stem cells 
The first hES cell line was derived in 1998 and ten years after that over a thousand new lines 
had been described [23]. Over the years, the derivation techniques and culture conditions 
have been improved. A lot of studies were done to avoid using undefined culture conditions 
which hinder the translation of hES cells use to the clinic. Defined culture components and 
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minimal exposure to animal-derived substances are required for the clinical use of hES cells 
[24]. 
Derivation of first hES cell lines were on mitotically inactivated mouse embryonic fibroblasts 
(MEFs) as feeder cells and the culture medium used for derivation was supplemented with 
fetal bovine serum (FBS) [8]. These undefined culture conditions create variability from 
batch to batch and also expose hES cells to pathogens and teratogenic components. Aiming 
for xeno-free culture conditions, initially, the animal-derived MEFs are substituted with 
human cells, the FBS with knockout serum replacement (KSR) as well as basic fibroblast 
growth factor (bFGF). However, KSR is not completely devoid of animal substances [25-27]. 
Few years later, it has been demonstrated that serum can be avoided and not used in the 
medium for culture, but bFGF should be supplemented in the medium since it is required for 
hES cell maintenance [28]. Feeder cells were replaced by extracellular matrices as an 
approach towards feeder-free and xeno-free culture condition. Matrigel is most commonly 
used in the coating of the hES cell culture plates. It is a mouse sarcoma tumor extracts 
containing a mixture of proteins, for example: laminin, collagen IV, and heparan sulfate 
proteoglycan. Later studies reported that recombinant vitronectin [29], a hydrogel [30], and a 
laminin-511(LN-511) fragment [31] can be used as alternatives to matrigel or feeder cells for 
culturing of hES cells. However, apoptotic inhibitors such as Rho-associated kinase inhibitor 
(Rock inhibitor) and small molecules inhibitor are needed for the clonal survival [32-34] and 
the cells need to be passaged in small clumps which can contain some differentiated cells.  
In addition to the previous methods of culture, synthetic scaffolds were used and shown to 
support survival and colony formation of hES cells [35, 36]. However, it is shown that in this 
culture condition the endogenously produced laminin by the stem cells themselves was 
facilitating the adhesion and survival of the hES cells [37]. To overcome this challenge, 
researcher reported culture of hES cells as single cell suspension without a need to add Rock 
inhibitor to the medium by using LN521 as a culture matrix [11, 38]. The first study of this 
thesis focused on the effects of LN521 on hES cells when used as a culture matrix.   
1.1.4.1 Laminins 
Laminins are a large family of heterotrimeric basement membrane adhesion proteins. They 
are highly specific to the cell and tissue type [39]. Each one of these proteins consists of one 
α, one β and one γ chain, and according to the chain composition, these proteins being named 
(for example LN-521 consists of α5, β2and γ1 chains) [40]. Around 16 laminin isoforms are 
known to exist in mammalian tissues to date, and most of them are recombinant proteins [41, 
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42]. It is shown that hES cells express alpha 1, alpha 5, beta 1, beta 2 and gamma 1 laminin 
chains and therefore suggested to express four isoforms of laminins, LN521, LN121, LN511 
and LN111 [43]. Moreover, alpha 5 chain laminins are expressed in the inner cell mass of the 
mouse blastocyst which makes us consider laminins containing alpha 5 chains as part of stem 
cell niche. Researches showed that LN521 is expressed in the embryo at early stages of 
development in the ICM from which all embryonic tissues developed [39]. It is also shown 
that it is expressed in some tissues in adult in a combination with other laminins, e.g., in the 
epithelium and surfaces of the oral cavity, gastrointestinal tract, urinary tract, skin, lungs and 
testis. It is also shown to be present in the nerve, muscle, endothelial and cardiac cells [44, 
45]. Moreover, laminins with alpha 5 chains are produced in vitro by hPS cells in culture and 
have autocrine and paracrine effects in regulating hPS cells survival and self-renewal. This is 
proven by a study showing dramatic reduction in hPS cells self-renewal and accelerated 
apoptosis with disruption and knocking down LAMA (laminin subunit alpha) gene [46]. 
LN521 supports long term self-renewal of the ES cells when used as a culture matrix in 
defined and xeno-free culture conditions [11]. Studies showed that hPS cells can be expanded 
on LN521 efficiently without using Rock inhibitor in defined xeno-free medium [11, 38, 47]. 
Moreover, it is shown that LN521 with E-cadherin support the derivation of hPS cell lines 
without a need to destroy the embryo. Avoidance of destroying the embryo could 
circumvents the ethical concern related to destruction of embryos for derivation of hES cell 
lines [11, 38]. In addition, studies showed LN521 allows the derivation of transgene-free iPS 
cells and their expansion efficiently [47]. LN521 was shown also to support culturing hPS 
cells in agitated conditions on microcarriers coated with LN521 [44]. Furthermore, it supports 
the differentiation of hPS cells to dopaminergic neurons when used as a culture matrix in 
xeno-free conditions [47]. Using LN521 as a culture matrix provides flexible culture 
protocols with possible weekend-free cells feeding which reduces the demands of stem cell 
culture [37]. However, detailed understanding of the effect of LN521 on hPS cells gene 
expression which could explain its positive effects on promoting self-renewal and 
pluripotency of hPS cells are not fully studied. In paper 1 of this thesis we studied the impact 
of using LN521 as a culture matrix on short term on hES cells gene expression. 
1.1.5 Differentiation of hPS cells into male germ cells 
Differentiation of hPS cells into germ cells is considered an important tool to study the early 
events of germ cells development occurring in human embryo. Using hPS cells as a model for 
germ cell development and differentiation will enrich our knowledge which was otherwise 
extrapolated from animal models and the species difference hinder the one-to-one translation 
 8 
of this knowledge to human. Moreover, differentiation of hPS cells in vitro provides future 
hopes and opportunity for treatment of infertility. Despite the great efforts done so far, we are 
not there yet. Different protocols were used starting from a single step embryoid body 
formation till multistep differentiation protocols with combination of different factors and 
different methods. The first attempt for in vitro differentiation of hPS cells towards germ cells 
was done by Clark and colleagues. They reported presence of Deleted in Azoospermia like 
(DAZL), Developmental Pluripotency Associated Protein 3 (STELLAR), DEAD-box 
polypeptide 4 (DDX4) and Synaptonemal complex protein 3(SYCP3) in the embryoid bodies 
[48]. EBs formation was used broadly as one step differentiation or as a combination of more 
steps on different types of cells or on matrices such as gelatin and matrigel [49-53]. Some 
studies used the two dimensional (2D) monolayer culture as a differentiation method in 
which hPS cells were cultured and differentiated on gelatin, laminin, polyornithine, feeder 
cells, gonadal stromal cells and matrigel [50, 54-59]. This approach leads to the generation of 
germ cell expressing SSEA1, DDX4, MutL Homolog 1(MLH1) and SYCP3. In 2015, a new 
differentiation strategy was introduced by Irie as well as Sasaki and colleagues. In their 
approach, they aimed to induce the cells into a mesodermal-like state before starting to direct 
them to differentiate towards germ cells. They used different matrices and a combination of 
2D and 3D methods of culture [60, 61]. Both groups reported production of human 
primordial germ cell like cells (hPGCLCs) with improved efficiency compared to previous 
published studies. However, the reproduction of these results remains challenging. 
Different factors have been tried and added to the differentiation medium. Bone morphogenic 
proteins (BMPs) were mostly used in the differentiation attempts and BMP4 is the most used 
factor [50-54, 56, 60-72]. Other factors such as leukemia inhibitory factor (LIF) and bFGF 
were also used as additives in the differentiation medium [55, 58, 61, 62, 70, 72-74]. Retinoic 
acid (RA) was reported to support inducing hPS cells differentiation into stage beyond PGCs 
[49, 62, 64, 70, 75-78]. In the recent years, additional factors such as, stem cell factor (SCF), 
Wnt family member 3A (WNT3A) and glial cell-line derived neurotropic factor (GDNF) 
have been employed for further experiments [60, 61, 66]. Moreover, some research groups, 
including our own data not included in this thesis (Ref Panula et al 2016; Plos One), used 
overexpression of different factors such as Deleted In Azoospermia (DAZ), DAZL, BOULE, 
DDX4, STELLAR and Nanos C2HC-Type Zinc Finger 3 (NANOS3), to promote hPS cells 
differentiation towards PGCs and male germ cells [56-58, 71, 78].  
Evaluation of the germ cells resulted from the in vitro differentiation is challenging since 
early human germ cells share expression of several genes and proteins with human 
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pluripotent stem cells. Defining the exact appearance of early germ cells is not well 
characterized yet. In addition, comparing results from different groups is difficult since the 
definition of a common and standardized evaluation protocol is still missing for human cells. 
E.g. DDX4 was used broadly by many groups to evaluate the presence of human germ cells 
after differentiation of hPS cells. Other markers such as: POU5F1, SYCP3, DAZL, cKIT, 
PRDM1, SSEA1 and STELLAR were among the most commonly used protein markers for 
evaluation of cells resulted from hPS cells differentiation. Furthermore, many groups reported 
the presence of haploid cells expressing acrosin in their differentiation protocols which 
should be taken with caution since these cells should have specific morphological 
characteristics of haploid spermatids [56, 57, 71, 73, 75]. Recently, with advanced progress 
toward understanding human germ cell specification in vivo, the spectrum of markers used 
for evaluation of the hPS cells differentiation increased as well. 
Differentiation of hPS cells into human germ cells is a challenge in the scientific field. 
Different approaches of analysis of the resulted cells and lack of standard criteria to define 
the first appearance of human germ cell hinder the comparison of the results obtained from 
different groups. Moreover, the overlap of the gene expression between the stem cells and the 
male germ cells in humans complicates the picture further. Furthermore, using different cell 
lines and sometimes in-house produced cell lines make it more difficult to judge the results 
since each hPS cells line is unique and different; furthermore, the same line behaves 
differently when cultured with different culture methods. This necessitates a robust culture 
condition, robust differentiation protocols as well as common baseline criteria to define the 
early specified germ cells. 
1.2 THE TESTIS 
The testis is a specialized organ. In early development, testes have a major impact on the 
regulation of normal development of male reproductive system by their hormonal secretion. 
Moreover, this organ is unique since it produces the gametes which transfer the genetic 
materials across generations. In this section, development of the human gonads, testicular 
cells development and spermatogenesis in mice and humans will be discussed. 
In brief, the testis is divided internally into two compartments: the seminiferous tubules and 
the surrounding interstitial tissue. The seminiferous tubules are long looped tubules, where 
spermatozoa production takes place. Theses tubules contain Sertoli cells and germ cells. The 
differentiation of spermatogonial stem cells (SSC) to mature spermatozoa starts at the 
basement membrane of the seminiferous tubules towards the lumen. When the formation of 
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the elongated spermatids is done, it gets released into the lumen. The seminiferous tubules 
drain into the rete testis which unite to form the ductuli eferentes and then drain into the 
epididymis. In the seminiferous part of the testis, a unique arrangement of Sertoli cells forms 
the blood-testes barrier (BTB). BTB is unique when compared to other tissue barriers. In 
addition to tight junctions, gap junctions, desmosomes and ectoplasmic specializations 
coexist and co-function together to form the BTB[79]. 
BTB plays a major role in isolating the developing germ cells and thus preventing an immune 
reaction against their cell surface antigens [80]. The outer layer of seminiferous tubules is 
surrounded by peritubular myoid cells. The interstitium consists of Leydig cells, fibroblasts, 
macrophages, lymphocytes, blood vessels, lymph vessels, loose connective tissues and 
nerves. These two compartments are responsible of the testes functions of spermatogenesis 
and steroidogenesis [80]. 
1.2.1 Germ cell development 
Germ cells are unique cells that secure the survival of a species by having the ability to 
transmit genetic information between generations. Germ cells are resulted from a complex 
developmental process that starts in the early stages of the embryo development and 
continues throughout the reproductive life of the individual. Our knowledge about the 
molecular and cellular mechanisms of the early germ cell development is still sparse. 
Inaccessibility of the embryo and the small number of germ cell population at the early stage 
of development lead to this limited knowledge. Most of the knowledge about human germ 
cell development is extrapolated from studies done in mice. Detailed information on the 
molecular and cellular mechanisms controlling the fate of the human germ cells is needed for 
better understanding of the human germ cell development. 
1.2.1.1 Specification and migration 
The specification events of human germ cells take place at day 9-16 of the embryo 
development. It is impractical to study these events since it is impossible to have human 
embryo at this stage for study and research purpose because of ethical and regulatory issues. 
As mentioned before, most of the knowledge of human germ cells development is 
extrapolated from mice; these early events of specification are studied in detail in mice. 
Specification of mouse germ cell precursors takes place in the proximal epiblast cells on 
embryonic day 6.25. The specification happens as a response to BMPs produced from the 
extraembryonic tissue [81, 82]. At E7.2, about 40 primordial germ cells (PGCs), which are 
ALP positive, are generated in the posterior primitive streak from the mouse germ cell 
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precursors [83, 84]. Then, these PGCs reside in the mesoderm of the yolk sac close to the 
junction with the allantois at E8 [85]. At this point of development, the corresponding 
developmental age of human embryo is 3-4 weeks. The earliest human PGCs were identified 
in the same location as mouse PGCs, close to the junction with the allantois [86, 87]. The 
characteristics of human and mouse PGCs are very similar. They are large round cells with 
large nucleus and are ALP positive [84, 86].  
The PGCs then migrate through the hindgut and its mesentery into the gonadal ridges at E8.5 
for mice and 5 weeks of development for humans. In humans, the PGCs start the migration 
from the allantois at week 4 and start to enter the gonads at week 5[88]. At week 6, the PGCs 
arrive at the final destination and colonize the developing gonads which occur at E11.5 for 
mice [86, 87, 89]. 
The migration of PGCs from proximal epiblast cells towards the developing gonads is a 
complex process which has some active and some passive events and it is influenced by 
many physical and directional signals. Moreover, the PGCs must increase in number and 
survive throughout the migration journey [87]. The exact details about the PGCs migration is 
not known; however, it is believed that the morphological rearrangement of the embryo plays 
the major role in directing the PGCs to migrate from the yolk sac into the hindgut [90].  
Later on, the PGCs may become able to migrate actively as they will have some changes in 
the morphology from round into irregular shape with some protrusions and pseudopodia [86]. 
There is a believe that the migration process is also mediated by the chemotaxic factors, KIT 
ligand, since it is found to be expressed in the PGCs [91, 92]. It is assumed that KIT ligand 
promotes the survival of the PGCs during the migration process, as it’s down regulation in 
mouse PGCs causes apoptosis which leads to failure of migration correctly [93]. KIT ligand 
is believed to play a major role in PGCs migration. However, the complexity of the 
mechanism of PGCs migration, survival, and proliferation requires more research and study. 
1.2.1.2 Colonization and sex determination 
After reaching the gonads, the human PGCs proliferate. The PGCs proliferation starts during 
migration but happens mostly in the gonads. It results in about 150.000 germ cells in males 
and 450.000 in females by week 9 of development [94]. Regulation of the in vivo PGCs 
proliferation is unknown yet; however, many studies showed that in vitro PGCs proliferation 
is regulated by many factors such as BMP4, LIF, bFGF and forskolin [95, 96]. At early stages 
of embryo development at the gastrulation period, the PGCs are still bi-potential and can 
form either oocytes or sperm. The fate of PGCs is not dependent on the germ cell sex but it is 
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influenced by signals from the surrounding environment from the fetal gonads [97]. Germ 
cell sex determination process and its molecular controlling mechanism are studied in detail 
in mice. Results revealed that RA and fibroblast growth factor 9 (FGF9) play a major role in 
this process [97]. RA triggers the entry of oogonia into meiosis in the fetal ovary by induction 
of retinoic acid gene 8 expressions (Stra 8). However, in the fetal testes, the retinoic acid gene 
8 (stra 8) level is low because retinoic acid is degraded by cytochrome P450, family 26, 
subfamily b, polypeptide 1 CYP26B1 (CYP26B1) which resulted in prevention of entry to 
meiosis. FGF9 is produced by Sertoli cells in the testis and causes inhibition of meiosis by 
maintaining the pluripotency markers expression [98]. In humans, it was hypothesized that 
RA and Stra8 have a role in the regulation of meiosis entry of the oogonia in the fetal ovary. 
Research results so far suggest a role of FGF9 in the regulation of prespermatogonia mitotic 
arrest but the triggering factors for it is not yet known, neither in humans nor in mice [98]. 
1.2.1.3 Bipotential gonads 
The development of the human embryo of both sexes is almost identical in the early period of 
gestation. After this period, the process of development differs at the anatomical and 
physiological level and results in male and female phenotype [99]. The development of testes 
in males and ovaries in females is directed by the chromosomal sex established early in 
advance at the time of conception [99-101]. Different multistep homologous but opposite 
mechanisms are involved in the male and female primary gonads differentiation [102]. 
Interstitial cell development and secretion of hormones are important for male gonads 
differentiation process. Presence of germ cells is not necessary for the development of male 
gonads at early stages of embryo [99]. In contrast, differentiation of female gonads requires 
the presence of female germ cells as well as the presence of functional somatic cells [99]. The 
primary male and female gonads in the fetus consist of three components: the primordial 
germ cells, the genital ridge mesenchyme and a layer of epithelium. The female phenotype 
develops far in advance to the histological differentiation which is the opposite to what 
happens in the male. In the male, the histological differentiation occurs before the phenotype 
development [99]. The process of gonadal development occurs as two phases: genital ridge 
appearing phase which is considered as the bi-potential gonad, followed by a phase of testis 
or ovary development [103]. Pre-Sertoli cells aggregate around the germ cells at 6-7 weeks of 
gestation and thus forming the primary sex cords which is considered the earliest 
distinguishable remark between the testis and the ovary at the early stages of development 
[100, 103]. The differentiation of the somatic cells of the future gonads plays an important 
role in directing the fate of the arriving PGCs. In an XY gonad, the differentiation of the 
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somatic cells is induced by SRY which upregulates SOX9 expression [104]. This leads to 
cellular and morphological changes including the differentiation of the Sertoli cells and the 
Leydig cells, and the formation of the testis cords around 7-9 weeks of development.  
1.2.1.4 Gonocytes 
When PGCs reach the male gonads, they become enclosed within the testis cords and from 
this time on, they are called gonocytes. “Gonocytes” is a general terminology used to refer to 
the fetal and neonatal precursors of undifferentiated SSCs, which are the reservoir of the 
germline stem cells. Gonocytes are a heterogeneous cell population with different expression 
profiles. They can be divided into 3 subpopulations: mitotic, transitional 1 and 2 pre-
spermatogonia [105]. Around the second trimester of gestation, most of the mitotic pre-
spermatogonia starts to lose their pluripotency protein expression and gain the expression of 
germ-cells specific proteins as they differentiate to transitional spermatogonia and become 
quiescent mitotically [105]. Gonocytes should migrate from the center of the seminiferous 
cords to the basement membranes to start the differentiation process. The number of 
gonocytes in the human fetal testes increases from around 3*10
3
 to around 3*10
4
 between the 
period 6-9 weeks post-conception [106]. The number of pre-spermatogonia increases 
dramatically and reaches around 4*10
4
 in the third trimester. The ratio of germ cells to Sertoli 
cells increases from 1:10 at week 6-9 of gestatin to 1:6 at 10-41 weeks of gestation. 
Transitional 2 pre-spermatogonia colonizes the basement membrane and is believed to form 
the spermatogonial stem cell (SSC) pool which maintains spermatogenesis in adulthood 
[105]. 
1.2.1.5 SSCs 
SSCs are the crucial cell type needed for the generation of sperm. These cells, like other stem 
cells, are defined by their ability to self-renew and to differentiate to other types of cells. 
SSCs result from differentiation of gonocytes. This process is characterized by changes in 
morphology and loss of some gonocytes markers, e.g. reduction in Placental Alkaline 
Phosphatase (PLAP) expression occurs first then followed by loss of expression of NANOG 
and POU5F1 [107]. However, the expression of some of these markers is still present and is 
detected in the testes in the early postnatal life. NANOG expression is found to be lost as 
early as 3 months and POU5F1 is still detectable till 3-4 months postnatally [108-110]. 
Whilst Melanoma Associated Antigen-4 (MAGE-4), Nanos C2HC-Type Zinc Finger 
1(NANOS-1) and DDX4 continue to be expressed in the human SSCs. Expression of 
POU5F1 in the human and mouse testes is different [111]. In humans, POU5F1 is not 
expressed beyond the gonocytes type while in mice it is expressed in spermatogonia till 
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adulthood [112-114]. In each species, there are different types of spermatogonia, and 
different variations were observed among different species [115]. SSCs undergo self-renewal 
to maintain the pool of cells needed for future spermatogenesis and at the same time provide 
the tissue with differentiating progenitors for the ongoing spermatogenesis. This role is taken 
by different types of cells in different species. For example in primates, including men, it is 
thought that Adark spermatogoina are the SSC which is considered as the regenerative reserve, 
and Apale are the functional reserve[116]. On the other hand, in mice, the A-single 
spermatogonia is considered as the stem cell which acts as the reserve and the progenitor cell 
as well [117].  
The process of self-renewal of SSCs is believed to be controlled by a unique 
microenvironment surrounding the SSCs: SSC-niche. This niche consists of several 
compartments such as: Sertoli cells, vasculature, interstitial compartment and the basement 
membrane [118]. It is believed that SSCs reside on their niche and to start differentiation a 
movement away from the self-renewal promoting niche is needed. Research done on murine 
SSC transplantation into a recipient mouse testes provided a support evidence of such 
phenomenon to occur in the testes when SSCs migrate towards their niche on the basement 
membrane after transplantation [119, 120]. 
1.2.2 Testicular somatic cell development 
1.2.2.1 Sertoli cell 
Differentiation and appearance of pre-Sertoli cells under the influence of SRY gene 
expression in the human embryo at 6 weeks post conception considered a crucial step in the 
development of human testes. In the human male fetus, somatic cells which express SRY, 
start to express sry-related high motility group (HMG)-box DNA binding protein (SOX9) as 
well [121]. Human female fetus somatic cells express SOX9 at early stages of development 
but it is lost dramatically since its expression lacks the enhancement from SRY gene 
expression as in male fetus [122]. Sertoli cells have a critical role during fetal development 
since they are the first cells differentiating from the precursor supporting cells. Their 
appearance is considered as the first indication that the bipotential gonads pass toward testis 
development. They surround the germ cells and form the testicular cord. During postnatal 
period, it is found that Sertoli cells dominate the cell population in the testes with limited 
number of undifferentiated germ cells [123, 124]. During puberty, the mean nuclear volume 
of Sertoli cells increases significantly, which is an indicator that Sertoli cells undergo 
maturation at puberty [123]. Sertoli cells have several functions to ensure normal maturation 
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of germ cells. They provide germ cells with physical scaffold toward the lumen of the 
seminiferous tubules during the process of differentiation. They also form the blood-testis 
barrier.Moreover; they create a suitable microenvironment for germ cells and their maturation 
and survival. Sertoli cells produce steroid and peptide hormones as they are equipped with 
rough and smooth endoplasmic reticulum and Golgi apparatus. 
Sertoli cells secrete peptide hormones such as anti-Mullarian hormone (AMH) and inhibin B. 
These hormones belong to a superfamily of glycoproteins similar in their structure to 
transforming growth factor-beta [125]. AMH, also known as Mullarian inhibiting substance, 
is produced by immature Sertoli cells after their initial differentiation around 8.5 weeks of 
gestation in humans. Expression of AMH by Sertoli cells is triggered by SOX9 as soon as 
testicular cord starts to assemble and Sertoli cells start to differentiate [126-128]. This 
hormone causes the Mullarian ducts regression during early periods of gonadal development 
which is considered an essential step in male sexual differentiation [129, 130]. Moreover, 
AMH is one of the earliest proteins, specific for Sertoli cells, expressed by the fetal gonads 
[126]. AMH was detectable in the male serum at the fetal life as well as perinatal period and 
is found to decline towards puberty which suggests its potential use to serve as a Sertoli cell 
maturation marker [131]. 
In female fetus, AMH is produced later and then the production continues throughout the 
female productive life by granulosa cells of small antral and primary follicles in the ovaries 
[129, 130, 132]. It has been shown that AMH was not detectable in the female fetus serum in 
human and other mammalian species [133]. The first time AMH expression was 
demonstrated in the developing ovaries was at the end of fetal life around 36-38 weeks of 
gestation [132]. In mature ovary, AMH is expressed by granulosa cells and is correlated with 
follicular development and ovarian cycle [132, 134]. These findings are in agreement with 
results shown in our in vitro study of human fetal gonadal tissue included in the thesis (paper 
III). 
Sertoli cells produce inhibins which play a role in FSH secretion control by negative 
feedback as shown by evidence from experiments on different species [135]. In addition, 
inhibins act as paracrine regulators in human testes and ovaries and they are produced by 
Sertoli cells in the testis and by granulosa and theca cells in the ovary. Active inhibins are 
found in two active molecular forms in the circulation, inhibin A and inhibin B, which consist 
of one a subunit and either bA or bB subunits for inhibin A and inhibin B respectively [136]. 
Both subunits are expressed in the testes from fetal life. Inhibin B is principally produced by 
Sertoli cells and its secretion and expression are correlated positively to their function [135]. 
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It is shown that inhibin B concentration in the circulation is correlated with sperm 
concentration, sperm count and testicular volume [137, 138]. Moreover, circulating levels of 
inhibin B reflect the normal and impaired process of spermatogenesis [137, 139-141]. Inhibin 
B is considered as a marker for spermatogenesis [135]. 
Studies done on inhibin B concentration in the male and female fetuses showed that there is a 
clear cut difference in which higher inhibin B concentration was detected in the cord blood of 
male babies compared to female babies and it was suggested to use this difference as a 
marker for fetal sex at the second trimester of pregnancy [142]. In females, inhibin B is 
considered the principal inhibin form during the follicular phase of maturation while inhibin 
A presents in the luteal phase of female menstrual cycle. Inhibin A can be used in the 
prognostic assessment in the prediction of resumption of ovarian function, while inhibin B is 
considered as an ovarian function marker and thus can be used to identify the potential 
response of the ovaries to ovulation induction [135].  
1.2.2.2 Leydig cells 
Leydig cells are located in the interstitium of the testes and their main function is production 
of testosterone from cholesterol. There are two known types of Leydig cells, fetal and adult 
Leydig cells. Fetal Leydig cells arise from the mesenchymal precursors of the gonadal ridge 
at the beginning of the 8
th
 week of gestation [143-146]. During the period 9-14 weeks of 
gestation, Leydig cells number and size increase and they occupy more than half of the 
parenchyma of the testes [143]. At about week 17-18 of gestation, the number of Leydig cells 
start to reduce gradually [143]. Production of testosterone at 7-8 weeks of gestation is found 
to be LH/hCG independent. However, the fetal Leydig cell main function in masculinization 
of the developing urogenital system is found to be LH/hCG dependent in the late gestational 
life [147]. The adult mature Leydig cells is found to be packed with smooth endoplasmic 
reticulum, which explains the main function of this type of Leydig cells in initiation and 
maintenance of spermatogenesis [143, 144, 146]. The Leydig cell function is regulated by 
luteinizing hormone (LH) and some autoregulatory factors acting autonomously on Leydig 
cells. Moreover, some paracrine factors secreted from cells in the seminiferous tubules 
regulate the function of Leydig cells. Leydig cells produce testosterone which is a 
fundamental player in initiation and regulation of spermatogenesis. During fetal life, higher 
concentration of testosterone was detected in male fetal serum compared to female fetal 
serum and this difference tends to decrease with advancement of fetal age [142]. During fetal 
life, testosterone plays a major role in the stabilization of the Wolfian duct derivatives, 
formation of external genitalia and accessory glands, and regulates the testes descend [99]. 
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During early neonatal life, at approximately 6 months after birth, the concentration of 
testosterone has been found to increase transiently with increase in LH and FSH [148]. 
During male reproductive life, testosterone acts with FSH hormone at different cellular sites 
and in a manner specific for each stage of sperm formation to ensure normal process of 
spermatogenesis [149].  
1.3 SPERMATOGENESIS 
The process of male germ cell proliferation and differentiation is called spermatogenesis. It 
starts when differentiating diploid SSCs start their cell division followed by sequential cell 
division of spermatogonia cells and finally the meiosis of spermatocytes which results in 
round spermatids formation [150-152]. Further differentiation of round spermatids into the 
spermatozoa is called spermiogenesis [150, 153]. Spermatogenesis takes 35 days in mice and 
64 days in humans [154]. In the mammalian testes, one SSC can produce two stem cells by 
undergoing self-renewing division which can be asymmetric division resulting in one stem 
cell and one differentiating cell, or symmetric division which results in two differentiated 
cells [154]. 
1.3.1 Mouse spermatogenesis 
In mice, at embryonic day 7.25–7.5, PGCs appear in the distal portion of the primitive streak 
and at the base of allantoic buds within the extraembryonic mesoderm. They are normally 
identified by high alkaline phosphatase (ALP) activity [84, 155]. 
Spermatogenesis in mice starts two days after birth when gonocytes located in the center of 
the seminiferous tubule [156] start to proliferate and migrate toward the basement 
membrane. By day six after birth all gonocytes would have migrated and resided at the 
basement membrane and became spermatogonia [155]. 
A primitive set of spermatogonia, known as undifferentiated spermatogonia, include: Asingle, 
Apaired, and Aaligned spermatogonia has stem cell properties [157-160]. In addition to the self-
renewing characteristics, undifferentiated spermatogonia generate differentiating 
spermatogonia which include A1, A2, A3, A4, intermediate, and B spermatogonia. B 
spermatogonia differentiate further into meiotic spermatocytes, haploid spermatids and 
spermatozoa. Spermatogonia cell types (Asingle to type B) are located on the peripheral 
basement membrane and the other cell types are arranged sequentially toward the lumen of 
the seminiferous tubule [161]. 
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1.3.2 Human spermatogenesis 
During this process, it is found that from one SSC 16 spermatids are formed in humans. This 
process is highly well controlled resulting in production of an average of 60 million sperm 
per ml of ejaculate [162, 163]. The process of sperm production is continuous all through the 
man’s life but it declines after 40 years of age [162]. 
Undifferentiated spermatogonia are located in the basement membrane of the seminiferous 
tubules and are semicircular in shape. Since the 1960s, human undifferentiated 
spermatogonia are classified into two groups: Adark and Apale, according to the intensity of 
their staining with hematoxylin [164]. Nevertheless, the identity of human SSCs is not 
described thoroughly. It is believed that Adark spermatogonia are quiescent and represent the 
reserve SSCs, while Apale are active mitotically and represent the active SSCs. Apale 
differentiate to type B spermatogonia, which itself is divided by mitosis and forms two cells 
that then enter meiosis and are named primary spermatocytes [165]. Before entering meiosis 
1, the primary spermatocyte undergoes one round of DNA replication in preleptotene phase. 
After that, it enters the meiosis 1 which consists of four steps: leptotene, zygotene, pachytene 
and diplotene. During meiosis I, primary spermatocytes become bigger in size and move 
towards the lumen of the seminiferous tubules. After completion of meiosis I, secondary 
spermatocytes are formed and they are smaller in size and undergo meiosis II immediately to 
form haploid round spermatids [165]. In the early stages of spermatogenesis during the 
mitotic division, the resulting cells stay connected together by intercellular cytoplasmic 
bridges which makes the maturation events happen in a synchronized way [162]. Some 
weeks following the production of round spermatid, the process of spermiogenesis starts and 
it results in the production of spermatozoa. It is divided into different phases: the Golgi phase, 
the cap phase, tail formation phase and the maturation stage. This process is controlled and 
guided by Sertoli cells [162]. During the conversion from spermatid to spermatozoa, dramatic 
changes happen to the spermatid, including condensation of the chromatin and the nucleus, 
reduction in the cytoplasm volume, and morphology changes, such as appearance of 
acrosome cap and a tail [165]. The mature spermatozoa are released to the lumen and then 
they mature further in the epididymis to become a functional sperm which is able to fertilize 
an oocyte [166]. 
1.4 FERTILITY PRESERVATION IN MALES  
Advanced achievements in the early detection and treatment of cancer resulted in increasing 
the number of cancer survivors [167, 168]. Thus, consequences of cancer treatment and 
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quality of life post cancer treatment became a hot topic and gained a lot of attention in the 
medical field recently. Most of cancer survivors desire having kids and families in the future 
and they feel that there was insufficient counselling about fertility preservation from their 
physicians before the initiation of the treatment [169, 170]. This brings the issue of fertility 
preservation (FP) into the focus of health care professionals, researchers, patients, patient 
families and the whole society.  
1.4.1 Effects of radiotherapy and chemotherapy on the gonads 
Improved chemotherapy and radiotherapy treatment protocols fortunately increased the 
survival rates over the years and more improvement is suspected in the coming years. 
However, these treatments are accompanied with late effects and may result in infertility or 
subfertility in those survivors. In addition, increased survival rates for childhood cancer lead 
to increased numbers of survivors reaching adulthood and here is when the issue of fertility 
preservation comes into the picture. Gonadotoxic agents are used to treat cancer and other 
non-cancer conditions such as autoimmune diseases [171]. Moreover, fertility preservation is 
an option for those who are receiving this gonadotoxic agents as well as patients with some 
chromosomal abnormalities leading to infertility in adulthood such as Klinefilter syndrome 
[171]. The radiotherapy and chemotherapy often have negative effects on the gonads and the 
reproductive capacity. This effect depends on factors, such as the duration of the treatment, 
the intensity of the treatment regimen, the dose of the drugs used and the type of the 
anticancer treatment used [171]. Alkylating agents-based chemotherapy and high doses 
cranial radiotherapy are considered the most harmful regimens to both ovaries and testes 
[172]. The risk of gonadotoxicity can be classified as low, in which only less than 20% of 
receivers experience infertility, intermediate, in which 21-80% experience infertility and 
high, in which more than 80% experience infertility [173]. 
1.4.1.1 Effects of radiotherapy on the testis 
Radiation is used as a treatment for the infiltration of the cancer itself or as a conditioning 
treatment before bone marrow transplantation. It exerts macroscopic and microscopic effects 
on adult testes resulting in reduction in the testicular weight and depletion in the seminiferous 
tubules and in the number of spermatozoa [174-176]. The main consequences for radiation in 
testes are reduced fertility and impaired DNA integrity [177-179]. The effect of radiation on 
the testes is found to be dose-dependent [171]; radiation can cause impairment of 
spermatogenesis at very low dose as low as 0.1-1.2 Gy. Higher doses of radiation can cause 
permanent azoospermia [178]. It is found that male germ cells are more sensitive to radiation 
compared to somatic cells which are found to be more resistant [180]. In prepubertal boys, it 
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is shown that dysfunction of Leydig cells appear at 20 Gy dose and in mature male at 30 Gy 
dose [180]. However, previous research showed that a dose of 9-10 Gy has produced gonadal 
dysfunction [181].  
1.4.1.2 Effects of chemotherapy on the testis 
Chemotherapy is considered the main stay in the treatment of cancer. Increased cytotoxicity 
of germinal epithelium when compared to Leydig cells, as is the case with radiotherapy, 
causes more pronounced and first adverse effects, appearing on spermatogenesis than in 
testosterone production. The effects of chemotherapy in causing azoospermia is agent and 
dose dependent and it is not dependent on the prepubertal status of the patient at the time of 
receiving the chemotherapy [182]. Leydig cells get affected after exposure to higher 
cumulative doses of gonadotoxic chemotherapy [183]. Nonetheless, recent data showed that 
there are more men with impaired testosterone production after chemotherapy at chemical 
and even at clinical level could be observed than what was described previously, and it 
manifests as metabolic syndrome, osteoporosis and erectile dysfunction as examples and they 
recommended initiation of testosterone replacement with monitoring [184, 185]. 
Based on their mechanism of action, chemotherapy agents can be classified into different 
classes; some of them are cell cycle specific while some are not. Alkylating agents, such as 
cyclophosphamide, are not cell cycle specific, but they modify the cell DNA chemically, and 
therefore affect the cell function. Carboplatin and cisplatin are considered alkylating-like 
agents since they work on DNA by cross linking the DNA. Antimetabolites, alkaloids and 
topoisomerase are cell cycle specific chemotherapeutics. Antimetabolites, such as 
methotrexate, are cell cycle specific and they act during the S phase of the cell cycle by 
interfering with the synthesis of DNA and RNA. Alkaloids interfere with the cell division at 
M phase by inhibiting the function of microtubules. Topoisomerase inhibitors act by 
inhibiting the proper coiling of DNA, and thus interrupting the normal process of DNA 
transcription and replication [178]. 
Since type B spermatogonia are proliferating rapidly, it is the type affected primarily by the 
chemotherapeutic agents as well as type A pale spermatogonia. On the other hand, the 
quiescent type A dark spermatogonia can restore the spermatogonial population (type A pale) 
if it is not affected by the chemotherapeutic agents which can explain the reversibility of 
azoospermia in some patients after receiving chemotherapy. However, if type A 
spermatogonia get affected partially or completely by chemotherapeutic agents, then 
irreversible loss of the stem cell population, and therefore of the whole process of 
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spermatogenesis can occur. There were initial thoughts that the prepubertal testes are less 
susceptible to insults from cytotoxic agents since the testes are less mature at prepubertal 
stage [186, 187]. However, later studies demonstrate that there is no difference between 
prepubertal and postpubertal testes in their susceptibility to the effect of chemotherapeutic 
agents [188, 189].   
Alkylating agents are found to be more gonadotoxic when used for cancer treatment 
compared to non-alkylating agents. Use of cancer treatment regimen containing alkylating 
agents is shown to cause prolonged azoospermia in 90-100% of the patients [190]. On the 
other hand, regimen containing non-alkylating agents caused transient azoospermia in about 
one third of the patients and most of those patients will have full recovery later on in life 
[191]. When chemotherapeutic agents with harmful effects to stem spermatogonia or to the 
process of their differentiation is avoided in the cancer treatment regimen, normospermia is 
found to be restored within three months after receiving the treatment [192]. However, when 
gonadotoxic agents are used, the stem spermatogonia cells get depleted and those surviving 
can remain in the testes, but their differentiation properties is affected for years after stopping 
the cancer treatment [193]. Some researchers demonstrated the negative impact of 
chemotherapeutic agents on Sertoli cells which could contribute to the impairment of 
spermatogenesis in patients receiving chemotherapy as treatment for cancer [194]. 
1.4.2 Options for FP for patients receiving gonadotoxic treatments 
There are several options for fertility preservation for children and adolescents receiving 
chemotherapy and radiotherapy as treatment which include: sperm cryopreservation and 
testicular tissue cryopreservation (TTC). Finding cancer treatment with no or minimal effects 
on gonads will be a great progress in the field of cancer treatment. However, improving 
malignant diseases control and treatment strategies with minimal side effects without 
affecting their efficacy is less likely. Prepubertal boys have no definite option for fertility 
preservation yet since they cannot produce sperm. The experimental option available for 
them is the testicular tissue cryopreservation which will be discussed in details here. 
1.4.2.1 Gonadal protection 
Shielding the testes or removing them from the irradiation field is well known as a protective 
measure [195]. Moreover, hormonal suppression of the teste by GnRH analogs is also known 
to be used as a protection measure, based on rendering the gonads less sensitive to the effect 
of the cytotoxic drugs by disruption of the gametogenesis [192]. Attempts towards 
development of hormonal gonadal protection strategy were not successful in both humans 
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and primates [192, 196, 197]. It is shown that treatment with GnRH analogs failed to preserve 
male fertility post sterilizing chemotherapy or to affect the spermatogenesis recovery speed 
after radiotherapy [198, 199]. 
1.4.2.2 Sperm Cryopreservation 
This method is the established fertility preservation method for those who are postpubertal at 
least Tanner stage 3 in the pubertal development [200-202].  It is recommended to be offered 
to all postpubertal patients with a recent cancer diagnosis as per the updated American 
Society of Clinical Oncology guidelines [200]. The best time for sperm cryopreservation is 
before the start of the therapy to insure having normal sperm for the collection since the DNA 
integrity and the semen quality may be affected by the chemotherapy even after only a single 
round of chemotherapy [200]. There are no guidelines for neither the quality of the semen 
before considering cryopreservation nor the duration of storage of sperm for fertility 
preservation [173]. The sperm samples can be obtained by masturbation or testicular sperm 
extraction (TESE), which is a direct sperm retrieval procedure from the testis for assisted 
reproduction technology in patients having azoospermia. In this procedure, identification of 
spermatogenesis foci in the seminiferous tubules is done under a microscope with 
microsurgical extraction of testicular tissues. This technique is used recently in patients with 
cancer to retrieve sperms and it is called onco-TESE [203]. 
1.4.2.3 Testicular tissue cryopreservation 
Prior to puberty onset, the fertility preservation options are limited to testicular tissue 
cryopreservation (TTC) because of the absence of mature sperm in the testes. In this 
approach, germ cells can be stored and can be used later on in different techniques for the 
purpose of fertility preservation. TTC is still experimental; however, it has great potential 
when it comes to fertility preservation in prepubertal children. It is performed by transscrotal 
excision through which testicular biopsy is harvested and then cryopreserved by slow 
freezing techniques either as cell suspension [204] or as tissue pieces [205]. This procedure is 
found to be well tolerated with minimal complications post operatively and with no delay in 
the cancer treatment [206-208]. Very low temperatures are used to preserve the intact cells or 
tissue. Cell survival after cryopreservation is affected by many factors including the effect of 
ice during the freezing and thawing process, type of cryoprotectant used and the rate of 
cooling. It is still a challenge to find optimal parameters for cryopreservation that are suitable 
for all types of cells needed to be cryopreserved [209]. This option of fertility preservation 
relies mainly on the future experimental techniques to produce mature sperm from SSCs 
[173].  
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1.4.3 Options for FP for prepubertal boys receiving gonadotoxic treatments 
Prepubertal boys are not able to produce sperm yet. Hence, the only option to preserve their 
future fertility is to cryopreserve their testicular tissue for possible use in the future. All 
available methods are still experimental, and the ongoing research is promising but faces 
many challenges. There are various techniques to use the cryopreserved prepubertal tissues as 
an option for fertility preservation: autologous transplantation, xeno-grafting and in vitro 
maturation of germ cells. In addition, use of hPS cells and differentiating them in vitro into 
germ cells might also be an option, which needs to be taken in consideration especially for 
patients who do not have any germ cells left at the time of tissue collection and 
cryopreservation, as we showed in our group publication in Human Reproduction journal 
which is not included in this thesis [210]. 
Since the in vitro maturation of gonadal cells is the focus of this thesis, we will discuss it 
more in detail. 
1.4.3.1 Male germ cells/ tissue autologous transplantation 
Transplantation of the cryopreserved testicular tissue or cells is considered a future option for 
fertility preservation for prepubertal boys. Transplantation of SSCs was successful in animal 
models mice, rat and rhesus monkey, and functional sperm production was reported [211-
214]. Moreover, it was also investigated in humans and reported that a percentage of 55% of 
the recipient testicular tissues contained transplanted cells [215, 216]. It is reported that 
quality and quantity of the transplanted SSCs play a major role in  the success of such method 
[211]. Transplantation of testicular tissue in mice proved to be more successful when 
compared to transplantation of SSCs suspension [217]. Testicular tissue grafting was shown 
to be successful in mice, rabbits, pigs and sheep and production of functional sperm from 
those grafting experiments was reported [218]. On the other hand, no report showed a 
successful grafting of human testicular tissue grafting experiments [218]. Transplanting 
testicular tissue or SSC in patients with cancer has a higher risk to reintroduce the cancer 
because of high possibilities of cancerous cells contamination [219]. However, 
transplantation of SSCs is considered a better option, but we are not there yet since 
decontamination protocols are still not achieved [220, 221]. The main difficulty here is that 
there are no definite specific markers to isolate SSCs purely [222]. Moreover, it is essential to 
increase the number of SSCs before the transplantation to ensure good success rate. This 
necessitates purification, isolation and in vitro expansion protocols for SSC before 
transplanting them. A lot of work has been done but such protocols are not available yet [223, 
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224]. All these challenges need to be addressed carefully to consider autologous 
transplantation as a clinical option for fertility preservation.  
1.4.3.2 Male germ cells/tissue xenotransplantation 
Transplantation of testicular cells across species is considered an option for fertility 
preservation. This technique was used in different species, such as mice, rats, hamsters, dogs 
and rabbits [225-228]. However, results showed success in some species while the approach 
in less closely related species failed. In these less closely related species, colonization of the 
donor germ cells into the recipient testes is observed, but the maturation to functional sperm 
was not achieved. And when it is achieved, the sperms were not normal [226, 227]. In 
humans, observation of meiotic activity in xeno-grafted human testicular tissue was shown, 
but no report yet of complete human spermatogenesis from this method [229-232]. Better 
results were demonstrated when immature tissues were used compared to mature tissues 
which indicates that this method could work for prepubertal human testicular tissues if used 
in the future as fertility preservation method [218, 232, 233]. However, this method is less 
favorable because of the risk of zoonosis and is suggested to be used as a method for 
investigating human tissue contamination with cancer cells before transplantation [234]. 
Nevertheless, in the absence of any other methods of in vitro maturation of human testicular 
tissue, this method is considered an option for future fertility preservation even though it is 
still experimental nowadays. 
1.4.3.3 In vitro maturation of germ cells 
There are two ways of generation in vitro germ cells: the first is by differentiation of hPS 
cells in vitro into mature germ cells, and the second is by maturation of SSCs in vitro. IVM of 
germ cells is considered a future option for fertility preservation by producing haploid germ 
cells in vitro, which could be used in principle for assisted reproduction therapy (ART) and 
embryo generation, and thus restoration of men fertility and ability to father kids. The 
drawback of using other methods such as germ cells transplantation with high risk of cancer 
re-introduction and the germ cells xenotransplantation with a risk of zoonosis can be 
overcome by in vitro maturation (IVM) of germ cells [235]. Remarkable effort was put in and  
good progress was achieved since this method was explored by researchers. Male sperms 
were produced from in vitro maturation of mouse testicular tissue and were functional [236]. 
However, the efficiency was low, and more modification and research are needed to optimize 
the results. On the other hand, no full spermatogenesis was reported in other species and in 
most experiments a stage of meiotic arrest was achieved which necessitates more research to 
understand the differences between the species and to explore the exact cause of failure of 
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mature germ cell production. In vitro maturation of germ cells in mice and humans was 
studied in paper II, III and IV in this thesis. 
As mentioned previously, the use of hPS cells can be an option for germ cells generation in 
vitro. The production of human pluripotent stem cells creates a lot of hope to the scientific 
field to differentiate and mature these cells into male germ cells in vitro and use the resulted 
cells in ART. The generation of hiPS cells makes it more attractive to potential clinical 
protocols to use those cells to generate the patient’s own germ cells in vitro using different 
differentiation protocols. Thus far, there is no report of functional mature human sperm 
generated from stem cell, neither hES cells nor hiPS cells. However, some forward steps 
were reported (see stem cells section 1.1.5). Use of stem cells in this aspect may provide new 
information towards establishing robust in vitro methods for germ cells maturation. 
Therefore, in vitro maturation of human germ cells is a promising option for fertility 
preservation for prepubertal patients receiving gonadotoxic treatment. Different methods 
have been used, including two-dimensional culture systems, three-dimensional culture 
systems and organ culture. In the following chapter these methods will be discussed with 
more focus on organ culture methodologies, as this is the technique which has been mainly 
used in the studies included in this thesis. 
Two-dimensional systems 
Culture of testicular cells as monolayer, alone or with other types of cells, was used broadly 
as attempts for functional spermatogenesis in vitro. This method was applied to different 
animals testicular tissues to study various aspects in regard to in vitro spermatogenesis (IVS), 
including: cell to cell and cell to extracellular matrix (ECM) interaction [237-241], properties 
of different testicular cell types when cultured together [242], and the effect of different 
growth factors and signaling molecules on the IVS [243-245]. As animal testicular tissues, 
human testicular tissues were cultured in 2D methods to explore the effect of different types 
of feeder cells when co-cultured with human germ cells and different types of supplements on 
the progress toward IVS [246-250]. Great effort has been done using this method of culture, 
although, no full IVS was reported. This can be explained by the lack of spatial arrangement 
of the testicular cells when cultured in 2D systems. 
Three-dimensional systems 
3D culture systems, either by culturing testicular tissue fragments or a combination of 
dissociated testicular cell in a supportive scaffold, were used as an attempt to allow the spatial 
arrangement of the testicular tissues. There are many publications showing some 
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advancement towards IVS using 3D to culture testicular cells combination in a scaffold. 
Different types of matrices were used as scaffolds (soft agar, methycellulose, collagen, 
calcium aliginate, poly-D,L-co-glcolic acid and matrigel) in combination with testicular cells 
from different species (mice, rats, calves, rhesus monkeys and humans) [251]. Furthermore, 
other researchers used carbon nanotubes and collagen sponges to explore the rat testicular 
organogenesis [252, 253]. Some groups reported that testicular cells aggregates could be used 
as scaffolds themselves when they are cultured in vitro and they could support germ cell 
maturation.[254]. Recently, testicular organoids, testis organ-like structure, were described by 
different groups and presented as a model applicable for establishment and study of IVS 
[255-257]. Despite the tremendous work scientists have carried out so far, they showed 
progression towards maturation of immature male germ cells until the stage of elongated 
spermatids in mice with low efficiency so far. More obstacles are needed to be overcome in 
order to establish a functional full IVS in human to consider this method as a clinical option 
for fertility preservation. 
Organ culture 
The organ culture methodology conserves the microenvironment arrangement and the spatial 
cellular arrangement of the tissue when cultured in vitro. This methodology was introduced in 
the early 1900s, when in vitro differentiation of germ cells was reported for the first time 
using an organ culture method [258]. Organ culture methodology includes hanging drop 
culture and air-liquid interphase culture. In hanging drop culture, the piece of the tissue is 
cultured within a small volume of medium and placed inversely in the lid of a culture dish. 
This method was used to study human and murine gonadal development including the testes 
as well as to study the effect of different factors on the development and maturation of germ 
cells [259-261]. In air-liquid interphase culture, the tissue fragments are cultured on a stand, 
allowing it to reach the medium to get the nutrients and the air to get the oxygen. This method 
was described in the early fifties by Trowell [262], and later on adapted by Steinberger when 
he used it to culture immature and adult rat testicular tissue [263, 264]. Since then, many 
research groups used the same method to promote IVS. Some groups used agarose as a stand 
to culture animal testicular tissue, e.g. murine [236, 265-274], rat [275, 276] and calf [277] 
testicular tissue. On the other hand, other research groups used a membrane as a stand for the 
testicular tissue fragments during air-liquid interphase culture and they cultured human foetal, 
prepubertal and adult testicular tissues [88, 278, 279]. Moreover, this method of culture was 
used to study and differentiate female gonads from different species, as well as to study male 
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and female gonadal development by culturing fetal gonadal tissues from mice, rats and 
humans [280-283]. 
Despite the great effort and considerable knowledge provided by these studies, functional full 
IVS was achieved only in mice by Sato and his group and the efficiency was low. More 
research is needed to explore the early germ cell development and factors controlling the 
process of human gametes formation and differentiation. Ongoing projects will enrich the 
field with more clues towards establishing a proper method for IVM of human testicular cells. 
This great step towards generating live fertile pups from mice in vitro cultured testicular 
tissues demonstrates that it could be possible in the future to have in vitro differentiated 
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2 AIMS 
The main aim of this work was to study the process of human male gonadal cell development 
and maturation using different in vitro models. Moreover, we focused in the study of in vitro 
models for human gonadal cell maturation and differentiation, aiming to assist in finding 
fertility preservation clinical options.  
The specific aims for each paper included in this thesis were: 
 To investigate the short term effects of LN521, when used as a matrix to culture hES 
cells, on the expression of stemness, pluripotency, and human gonadal cells related 
genes as an approach for future robust in vitro hES differentiation protocols towards 
germ cells. 
 To investigate the effect of supplementation of KSR, melatonin, and glutamax on 
murine testiculr tissue maturation in vitro. 
 To use air-liquid interphase explant culture method to culture human fetal gonadal 
tissues in vitro and evaluate their endocrine functions.. 
 To assess the in vitro functions of Leydig cells and Sertoli cells of human testicular 
tissues, from prepubertal boys subjected to treatment for hematological and 
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3 MATERIALS AND METHODS 
3.1 ETHICS 
3.1.1 Animal tissues 
The approval for animals use and handling was obtained from the ethics committee for 
experimental laboratory animals at Karolinska Institutet (N489/11 and N280/14). 
3.1.2 Human tissues 
3.1.2.1 First trimester gonads 
The Regional Human Ethics Committee, Stockholm, Sweden, approved the tissues collection 
(Dnr 2007/1437-31 with complementary permissions 2011/1101-32 and 2013/564-32). The 
ethical approval to perform the gonadal studies: Dnr 2013/457-31/4. 
3.1.2.2 Human prepubertal boy testicular tissue 
The approval for testicular tissues collection from the patients was obtained from the Ethics 
Board in Stockholm (Dnr 2013-2129-31-3, Dnr 2014/267-31/4, the National Ethics Board of 
Iceland, Reykjavik (VSN 15-002) and the Ethics Board of the University of Helsinki 
(426/13/03/03/2015).  
3.1.3 Stem cells 
Ethics approval for the derivation and differentiation of the hES cell lines was obtained from 
the Regional Ethics Committee in Stockholm (Dnr. 454/02). 
3.2 CELL LINES AND TISSUES 
3.2.1 hES cell lines (Study I) 
Human embryonic stem-cell lines (HS360, HS364, HS380, HS401 and HS420), all karyotype 
46 XY, were derived by mechanical isolation of the inner cell masses of six-day-old embryos.  
3.2.2 Mouse tissue (Study II) 
Wild-type C57/BL6 pregnant mice were purchased from Charles River (Sulzfeld, Germany). 




3.2.3 Human tissue 
3.2.3.1 First trimester gonads (Study III) 
Human first trimester embryonic/foetal gonadal tissues (4.5-10.5 weeks post conception) 
were collected after elective surgical abortions and maternal written informed consent. All 
cases were tested and negative for HTLV, HIV, HBV, HCV and Syphilis infection. A total of 
27 ovaries and 28 testes, from 55 individual embryos, were collected and included in the 
study. The tissues were dissected in physiological sodium chloride solution under sterile 
conditions within 1 hour after surgery. Directly thereafter, the tissue was transferred to 
Knock-out Dulbecco's Modified Eagle Medium (KO-DMEM, 10829-018, Invitrogen).  
3.2.3.2 Human prepubertal testicular tissue (Study IV) 
Eighteen prepubertal boys from Sweden, Finland and Iceland, undergoing treatments 
implying a very high risk of infertility, were enrolled in an experimental procedure for 
testicular cryopreservation, within the NORDFERTIL research programme. Inclusion criteria 
were planned allogeneic or autologous HSCT, or testicular radiotherapy. Testicular volumes 
>10ml (measured by orchidometer), a high bleeding or infection risk were considered 
exclusion criteria. Written and verbal information about the research project was given to the 
parents, and when appropriate to the patient, before they agreed to give their written informed 
consent. After unilateral open testicular biopsy, where less than 20% of the testicular volume 
of one testis was collected, two thirds of the tissue was cryopreserved for clinical fertility 
preservation [284] and the other third was transported to the NORDFERTIL research 
laboratory at Karolinska Institutet. 
3.3 CELL AND TISSUE CULTURE 
3.3.1 Stem cell culture 
3.3.1.1 On feeders 
hES cells were cultured on mitotically inactivated hFFs (CRL-2429, ATCC, Manassas, VA, 
USA) in  knock-out (KO) DMEM medium (KO-DMEM, 10829018, Invitrogen, Life 
Technologies,  Paisley, Scotland) containing 20% KO Serum Replacement (KO-SR, 
10828028, Invitrogen),  0.5% penicillin-streptomycin (15140122, Invitrogen), 2mM L-
GlutaMAX (35050038,  Invitrogen), 1% non-essential amino acids (11140035, Invitrogen), 
0.5mM 2-mercaptoethanol  (31350010, Invitrogen) and recombinant human fibroblast growth 
factor 2 at 8 ng/ml (FGF2, 234-FSE/CF, R&D Systems, Minneapolis, USA). 
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3.3.1.2 On matrices 
To enable hES cell culture on LN521- and LN121-coated plates, LN521 and LN121 were 
slowly thawed at 4°C for one to two hours and diluted at a 1:10 ratio with Dulbecco's 
phosphate-buffered saline containing CaCl2 and MgCl2 (DPBS++) to a final concentration of 
10 μg/ml. The plates were then coated with LN521 or LN121 at 5µg/cm² overnight at 4 ̊C 
followed by one hour at 37 ̊C or for two hours at 37 ̊C according to the manufacturer’s 
instructions. The hES cells were cultured in NutriStem medium (NutriStem hESC XF, 05-
100-1A, Biological Industries Israel Beit Haemek 120 Ltd., Israel) at 37 ̊C and with 5% CO2, 
with daily medium change.  To perform hES cell culture on Matrigel-coated plates, Matrigel 
was thawed on ice at 4°C overnight. Plates were incubated with Matrigel diluted 1:84 in 
NutriStem at 4°C overnight or  at room temperature for 1 hour. The cells were passaged 
enzymatically using TrypLE select (12563011, Invitrogen) every five to seven days. After 
three to four passages, the cells were expanded to collect material for analysis. 
3.3.2 Stem cell differentiation 
After reaching confluence on LN521-coated plates at passage nine, hES cells were allowed to  
form embryoid bodies (EBs) in 24-well ultra-low attachment plates (#3473; Corning) for 14 
days in NutriStem without growth factors (#06-5100-01-1A; Biological Industries). The EBs 
were then either plated on LN521 -coated culture plates or chamber slides (#354104, 
Corning) for an additional 14 days. After a total of 28 days, differentiated cells were either 
used for gene expression analysis or fixed with 4% paraformaldehyde for 
immunocytofluorescence analysis. 
3.3.3 Mouse testicular tissue culture 
To culture mouse testicular tissue, we used the testicular explant culture method described 
originally by Sato et al [236] (see figure 2). To prepare the agarose pillar, pre-autoclaved 
0.7% SeaKem_ LE agarose (50004, Lonza, Basel, Switzerland) was mixed with the relevant 
culture medium 1:1 v/v to give a final concentration of 0.35% agarose. The different culture 
conditions used were; (1) minimum essential medium alpha (MEMa; 22561-021, Gibco) + 
melatonin (M5250, Sigma Aldrich, Munich, Germany, final concentration 1027 M) (2) 
MEMa + Glutamax (32561-029, Gibco, 1.87 mM Glutamax), (3) MEMa + 10% Knockout 
Serum Replacement (KSR, 10828-028, Gibco), (4) MEMa + Glutamax + melatonin, (5) 
MEMa + Glutamax + 10% KSR, (6) MEMa + Glutamax + 10% KSR + melatonin, (7) 
MEMa + melatonin + 0.1% KSR, (8) MEMa + melatonin + 1% KSR, (9) MEMa + melatonin 
+ 10% KSR, and (10) MEMa + melatonin + 20% KSR. The tissue was cultured at 34.5 ̊C, 
and 5% CO2. 
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3.3.4 Human first trimester gonads culture 
The first trimester gonadal tissue samples were cultured using a culture method adapted from 
testicular explant culture method published by Sato et al [236]. The first trimester gonadal 
tissues were cultured on agar blocks in air-liqiud interphase (as described in section 3.3.3.). 
The cell culture medium was Knock-out Dulbecco's Modified Eagle Medium (KO-DMEM, 
10829-018, Invitrogen) supplemented with 10% (v/v) knock-out serum replacement (KO-SR, 
10828-028, Invitrogen) and 1% (v/v) penicillin/streptomycin (Pen/Strep, 15140-122, 
Invitrogen). The gonadal tissue was received as both gonads with mesonephros from the 
same fetus. One gonad was used as control to the experiments. The remaining gonad  was cut 
into three small pieces; each approximately three mm3 in size and placed on top of the 
agarose pillars, one piece per pillar being soaked, but not covered, by the culture medium. 
The gonadal tissue was cultured at 37°C and 5% CO2 for 14 days. The culture medium was 
collected every seven days, stored in -80°C until evaluation, and replaced by fresh medium. 
At the day of culture termination, both media and tissue were collected. Media was stored in -
80°C until evaluation. 
3.3.5 Human prepubertal testicular tissue culture 
Testicular samples were cultured in a modified air-liquid interface system as described 
previously. Upon arrival to the lab, samples were washed with NutriStem® (05-100-1A, 
Biological Industries, CT, USA), 1% (v/v) pen/strep (1% pen/strep; 15070-063, Gibco, 
Thermo Fisher Scientific, MA, USA) and their size and weight were registered. Samples 
were dissected into small fragments (approx. 1mm3) and cultured on top of soft-agarose 
(50004, Lonza, Basel, Switzerland) stands in an air-liquid interface up to 21 days. 
NutriStem® supplemented with 1% pen/strep, 10−7 M melatonin (M5250, Sigma Aldrich, 
Munich, Germany) and 10% (v/v) KSR XenoFree (KSR; A1099201, Gibco, Thermo Fisher 
Scientific) was used as culture medium for all patient groups. Culture medium was added to 
the culture wells (2 mL) up to the edge of the agarose-stands without covering the testicular 
fragments and changed weekly. 
 
 
Figure 2. Schematic representation of the air-liquid interphase organ culture 
used in the thesis 
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3.3.6 First trimester tissues age determination 
The postconceptional age of tissue was determined by examination of anatomical landmarks 
such as limb, nervous system, gonadal and eye development according to the atlas of life 
before birth [285]. The tissue collected was not intact, why crown rump length (CRL) or neck 
rump length (NRL) often was not possible to measure. The exactness of staging may differ a 
maximum of  0.5 week. 
3.4 STAINING 
3.4.1 Embedding and sectioning 
Tissues collected at the end of the culture were fixed either in Bouin’s solution (HT10132, 
Sigma-Aldrich) or in PFA (02176, Histolab, Gothenburg, Sweden) at 4°C overnight. After 
that dehydration was done in ascending ethanol concentrations (30%, 50% and 70% ethanol) 
for 24 hours each and (80%, 96% and 99.6% ethanol) at least for 6 hours each, at RT. Then 
the samples were transferred to butyl acetate (45860, Sigma-Aldrich) overnight at RT. 
Samples were embedded in melted paraffin (ParaplastX-TRA®, P3808, Sigma-Aldrich) at 
61°C overnight, left to cool and solidify and then cut into 5μm sections by a Biocut 
sectioning machine (Reichert-Jung, NY, USA).  The sections were placed on microscope 
slides (10143352, Superfrost Plus, Thermo Scientific, MA, USA) and dried in an oven 
overnight at 37°C. 
3.4.2 Immunohistochemistry 
After de-paraffinization for the sections of formaldehyde 4% fixed samples, antigen retrieval 
was performed in 50 mM glycine (pH 3.5, ≥90 °C maintained for 10 min). The primary 
antibody was applied for overnight incubation at 4 °C in 0.1% BSA/TBS. Negative control 
sections were incubated with 0.1% BSA/TBS without primary antibodies. Subsequent steps 
were performed at RT, with TBS washes between incubations. Primary antibody binding was 
detected using Vectastain ABC kit Universal according to the manufacturer’s instructions 
(PK-7200, Vector Laboratories). 
3.4.3 Immunofluorescence 
For immunocytofluorescence analysis of cells, cells were fixed with 4%  paraformaldehyde 
for 15 minutes, washed three times with 1× phosphate-buffered saline (PBS) and 
permeabilized with 0.3% Triton X-100 (#108643, MERCK, Germany) in PBS for ten 
minutes. After blocking for one hour with 5% donkey serum (125558, Jackson Immune 
research), 1% bovine serum albumin (BSA; 001-000-162, Jackson-immunoresearch) and 
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0.1% Tween20 (#655205, MERCK) in 1× PBS at room temperature, the cells were incubated 
with primary antibodies in antibody solution (1% donkey serum, 0.1% BSA and 0.1% 
Tween20 in PBS) at 4◦ C overnight (Supplementary Table 2). Next day, the cells were 
washed three times with 1× PBS and incubated with secondary antibodies (donkey anti-
mouse Alexa Fluor 488 conjugated (715-546-150, Jackson-immune research) or donkey anti-
rabbit Cys3 conjugated (11488299, Fischer Sci.)) in antibody solution for one hour at room 
temperature in the dark and afterwards counterstained with DAPI at 1 µg/ml (PureBlu DAPI, 
135-1303, BioRad) for 15 minutes.  
For paraffin embedded sections, the sections were de-paraffinized a dehydrated using xylene 
followed by a descending ethanol series. After that, samples were antigen retrieved in 10mM 
sodium citrate buffer at PH of 6 at 95◦C. Subsequently, tissues were blocked with serum from 
the same host where the secondary antibody was produced. Incubation with the primary 
antibodies of interest overnight at 4◦C was followed by washing steps. In the last step, the 
tissue sections incubated with fluorescent-dye conjugated secondary antibodies and mounted 
with mounting medium containing DAPI. 
3.4.4 Periodic acid Schiff staining  
Sections of the samples were de-paraffinized in xylene and rehydrated in descending ethanol 
concentrations; 99.6%, 96% and 70%, for ten minutes each at RT. The PAS kit (101646, 
Merck, Darmstadt, Germany) was applied to stain the sections in accordance with the 
manufacturer’s protocol. The sections were then washed in distilled water twice for five 
minutes each. Afterwards, the sections were incubated with periodic acid for five minutes and 
washed under tap water for three minutes, followed by washing in distilled water twice for 
five minutes each. The sections were then incubated with Schiff’s reagent for 15 minutes at 
RT and washed again under tap water for three minutes, followed by washing in distilled 
water twice for five minutes each. Afterwards, some tissue sections were counter-stained with 
haematoxylin (Mayer’s Hemalaun solution, 1092491000, Merck) for two minutes, followed 
by washing under tap water. The sections were then de-hydrated in ascending ethanol 
concentrations; 70%, 96%, and 99.6%, followed by xylene, each for ten minutes at RT. To 
mount the sections, Entellan® new (1079610100, Merck) was applied on the sections. 
3.5 HORMONE MEASUREMENT 
3.5.1 Enzyme-Linked Immunosorbent Assays (ELISA) 
Conditioned medium from organ cultures was collected in order to evaluate the production of 
testosterone, inhibin B and AMH during the culture period. Hormone concentrations were 
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determined by specific enzyme-linked immunosorbent assays (ELISA) according to the 
manufacturer’s instructions. Two technical replicates were performed for each sample. The 
microplate reader Fluostar Omega (BMG LabTech, Ortenberg, Germany) was used for 
reading the absorbance at 450nm. The standards provided with the kits were used for 
generating a standard curve. 
3.5.2 Mass spectrometry 
The concentration of total testosterone in the media was determined by Liquid 
Chromatography-tandem Mass Spectrometry LC-MS/MS at the Karolinska University 
Hospital Laboratory, Stockholm, Sweden. 
3.6 GENE EXPRESSION ANALYSIS 
3.6.1 RNA isolation and cDNA amplification 
HES cells were harvested using enzymatic digestion with TrypLE select. RNA isolation was 
performed using a RNeasy kit (#74104, Qiagen, Germany) according to the manufacturer´s 
protocol and treated with DNase (RNase-free DNase SET, 79254, Qiagen). CDNA was 
synthesized using an  iScript cDNA synthesis kit (#170-8891, Bio-Rad), following the 
manufacturer´s protocol. 
3.6.2 Taqman Low Density array 
To compare the five hES cell lines, the expression of 96 genes was analysed using Taqman 
low density (TLD) array cards (4385344, Applied Biosystems, Carlsbad, CA 92008, USA),  
designed by the International Stem Cell Initiative, according to the manufacturer’s protocol.  
Briefly, the TLD array cards were preloaded with 96 TaqMan probes which were run at the 
same time. Included in the 96 genes were markers of undifferentiated stem cells, pluripotency 
maintenance, stemness and differentiation, and six internal controls. The data was analysed 
using RQ-Manager 1.2 Software. All the hES cell lines were run in three biological 
replicates. 
3.6.3 Quantitative polymerase chain reactions 
Quantitative PCR was performed using TaqMan Universal PCR Master Mix (#4369016, 
Applied Biosystem) with TaqMan probes (Applied Biosystem) according to the 
manufacturer’s protocol. GAPDH was used as an internal control. 
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3.7 FLOW CYTOMETRY 
Samples for flow cytometric analysis were prepared as previously described by Rotgers and 
colleagues [286]. Briefly, cultured testis pieces were cut using McPherson- Vannas scissors 
and enzymatically digested by using 1 mg/mL collagenase/dispase (10269638001, Roche, 
Basel, Switzerland), 1 mg/mL hyaluronidase (H3506, Sigma–Aldrich), 1 mg/mL DNAse1 
(DN-25, Sigma–Aldrich). Resulted Cell suspensions were filtered and subsequently fixed and 
permeabilized using 4% paraformaldehyde and 90% methanol. Immunolabeling with mouse 
anti- γH2AX-Ser139 antibody (05-636, EMD Millipore Billerica, MA, USA), which is a 
marker for meiosis, was performed to assess the different germ cell population in the 
testicular pieces. 
3.8 STATISTICAL ANALYSIS  
To perform the statistical analysis, t test, One-way ANOVA, ANOVA on ranks and 
Spearman rank correlation were specifically applied for the different experimental contexts as 
described for each study, using the Sigma Plot software ver.12.0 (Systat Software Inc.,IL, 
USA). The means and standard deviations were used in the figures as indicated and each 
experimental condition was repeated at least 3 times. A p value ˂0.05 was considered to 
indicate a significant difference. 
For TLD array analysis, TLD array data was normalized using GAPDH as a housekeeping 
gene control and undetected genes were removed. To separate and compare gene expression 
profiles of cell lines, the dCT means of replicates were plotted in a heatmap, separating cell 
lines using hierarchical clustering. Moreover, common patterns of expression were 
investigated via intersection of genes with high expression, arbitrarily defined as exhibiting 
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4 RESULTS AND DISCUSSION 
4.1 GENE EXPRESSION ANALYSIS OF HUMAN ES CELLS CULTURED ON 
LN521 
The derivation of clinically safe hES cell lines has proven to be challenging, and this limits 
the use of PS cells in personalized medicine. In addition, more defined culture conditions will 
help in interpretation of results obtained from hES cell experiments and improve our 
understanding of the mechanisms controlling hES properties and characteristics. Moreover, 
establishing robust and reproducible culture conditions will make PS cells more suitable to be 
used for future challenging differentiation protocols, such as differentiation towards germ 
cells. To obtain this, the use of the synthetic matrices to culture hES cells would result in 
better-controlled conditions. The introduction of LN521 as a matrix for hES cell culture was a 
step forward for clinically safe hES culture condition. In this paper, we cultured five male 
hES cell lines initially derived on hFFs using LN521 as a matrix to examine the behavior of 
these cells in terms of pluripotency characteristics as well as important genes for male 
gonadal development when cultured for short period on LN521. Furthermore, we compared 
the gene expression of these hES cell line cultured on LN 521 with the gene expression when 
they were cultured on LN121, hFFs and matrigel, to investigate the differences of using these 
substances as matrices for hES culture. Moreover, we explored the effect of LN521 on the 
expression of genes related to human gonadal cells. 
4.1.1 Pluripotency state of hES cells cultured on LN521 
After being cultured on LN521 for four passages, the hES cells from five hES cell lines 
(HS360, HS364, HS380, HS401 and HS420) analysed by TLD arrays. Results of this 
analysis showed higher expression of genes related to stemness (ZFP42, TDGF1, SFRP2, 
PODXL, NR6A1, CD9, DNMT3B, IFITM1 and LIN28) and lower expression of genes 
related to differentiation (TAT, PAX4, IAPP and DDX4).  The karyotypes of all five cell 
lines were 46, XY after four passages on LN521.  
The five hES cell lines then cultured on LN521 for nine passages and after the ninth passage 
their pluripotency characteristics were examined by gene expression, protein expression and 
by differentiating them to three different germ lines cells. Immunofluorescent staining 
revealed positive staining of five known pluripotency markers NANOG, POU5F1, SOX2, 
TRA-1-60 and SSEA4. Quantitative analysis of the expression of NANOG, POU5F1 and 
SOX2 revealed no significant differences between the five hES cell lines. 
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The ability of the cells from all five hES cell lines to differentiate spontaneously into the three 
germ layers was evaluated by differentiating the cells in vitro by formation of embryoid 
bodies. After 28 of in vitro spontaneous culture as embryoid bodies, all the hES cell lines 
expressed ectoderm (TUJ1), mesoderm (alpha SMA) and endoderm (AFP) markers. At the 
gene level cells from all hES cell lines showed expression of ectodermal (NEUROD 1, 
PAX6), mesodermal (KDR, ACTC1), endodermal (GATA6, AFP, DDX4) and trophoblast 
(KRT7) markers. 
4.1.2 Homogenized gene expression profile for hES cells cultured on LN521 
To investigate the effect of utilizing LN521 as a matrix for hES cell culture, we analyzed the 
expression of pluripotency, stemness and male gonadal cells related genes by qPCR. First of 
all, we compare the expression of the genes when hES cells cultured on feeders using two 
different media, DMEM and NUTRISTEM. The analysis of this part revealed a similar 
expression pattern and by this, we can confirm that the change of the culture medium to 
NUTRISTEM when culturing the cells on matrices has no effect.  
When gene expression of hES cells cultured on hFFs and on LN521 at p4 analyzed, we 
observed more gene expression variation of cells cultured on hFF compared to cells cultured 
on LN521 at p4. 
Comparing the pluripotency gene expression of the hES cells cultured on LN521 for four and 
nine passages showed less variation with prolonged culture. The variation of a specific gene 
was analyzed by comparing the coefficient of variance which is determined by calculating the 
ratio between the SD and the mean value of all cell lines together. NANOG and GDF3 
showed a variation of less than 50% at p9 from more than 50% at p4. POU5F1 and SOX2 
showed a reduction in the variation from less than 50% at p4 to less than 25% at p9. 
4.1.3 Gene expression profile of hES cultured on LN521, LN121 and hFF 
To study the difference between LN521 and other matrices used for hES cells culture, two 
hES cell lines (HS360 and HS380) were cultured on LN521, LN121 and Matrigel. Cells 
cultured on LN121 and Matrigel had a higher incidence of differentiation compared to those 
cultured on LN521. Moreover, hES cells cultured on LN121 were slower in attachment and 
growth compared to hES cells cultured on LN521. This difference between LN521, LN121 
and Matrigel became more pronounced with prolonged culture. 
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4.1.4 Effect of culturing hES cells on LN521 on the expression of gandal cell 
genes. 
LN521 has been shown by other researchers to be present in the decellularized matrix of 
human adult testis [45]. To investigate the effects of LN521, when used as a matrix for hES 
cells culture on the expression of genes related to male gonadal cells, we included male 
gonadal cell related genes in the gene analysis of the hES cells after p4 and p9 of culture. The 
results showed different patterns of variation of such genes between p4 and p9. 
4.1.5 Discussion 
Incomplete defined culture conditions and the use of xenogenic materials for hES cell culture 
and expansion are main challenges towards establishment of well-defined culture condition 
for clinically safe hES cell lines. The use of synthetic matrices would result in better 
controlled conditions for hES culture. HES cells express alpha1, alpha5, beta 1, beta 2 and 
gamma 1 laminin chains. Therefore, LN521 was suggested to be expressed in the hES cells 
with other forms of laminin, LN121, LN511 and LN111 [43]. Moreover, alpha 5 containing 
laminin isoforms thought to be part of stem cell niches since the alpha chain laminins are 
found in the inner cell mass of the mouse blastocyst [287]. Therefore, in this work, we aimed 
to investigate if LN521 could be an optimal matrix for hES cells previously derived and 
cultured on feeders as a step for well-characterized hES lines to be used in the defined 
differentiation protocols for regenerative medicine applications purposes. 
Our results showed stable hES cell lines after being transferred from hFF to LN521 and 
cultured for a short period on LN521. Cells were growing as monolayer and reaching 
confluency within five to seven days without any signs of differentiation. Our results agree 
with previous studies showing feasibility of using LN521 as a matrix for hES cell culture in 
xeno-free and chemically defined culture systems. However, our results showed the short 
term culture effect of LN521. A future study of the longterm effects of using LN521 as a 
culture matrix for hES cells is needed to confirm our results. 
In our study, we observed variations in the expression of pluripotency genes and 
differentiation genes among the five cell lines which indicate the cell line specific expression 
pattern. However, investigating the expression of pluripotency genes of the hES cells cultured 
on LN521, we observed a homogenized expression profile compared to those cultured on 
feeders and more pronounced when the culture on LN521 was prolonged. This is an 
indication for more predictable and robust culture conditions of hES cells which is of great 
help toward establishment of directed and cell line independent differentiation protocols. 
 44 
Our results showed a similar picture of variation in the gene expression for cells cultured on 
feeder using two different media (DMEM and NUTRISTEM) which indicates that the change 
to NUTRISTEM when culturing the cells on LN521 had no obvious effect. We concluded 
that the homogenization effect we observed is a result of using LN521 as a matrix for hES 
cell culture. 
When LN521, LN121, and Matrigel were compared when used as a matrix for hES cell 
culture, we showed that LN521 provides a suitable matrix for hES cell attachment, growth, 
and self-renewal. The difference in the alpha chain between two types of laminins; LN521 
and LN121 could be an explanation of the differences we observed. However, future studies 
are needed to investigate the effect of this differences and its impact in the long term culture. 
Since LN521 was shown to be expressed in the human testis decellularized matrix, we 
investigated the potential effects of LN521 on gene expression levels of early gonadal germ 
and somatic cells. Genes related to the specification and appearance of early stage of 
primordial germ cells in humans, genes related to gonadal somatic cells and NODAL 
pathway related genes which play a great role in early cell fate including germ-cell 
specification were included in the analysis. We showed here that LN521 had no effects on the 
expression levels of genes related to early gonadal cells. This indicates the possibility of 
using LN521 to culture hPS cells tend to be used for differentiation toward human germ cells. 
However, more obstacles in the differentiation of hPS cells towards germ cells are related to 
our lack of understanding about the exact mechanisms and process of human germ cells 
differentiation which necessitates studying normal and pathological human gonadal tissues as 
well as mature and immature gonadal tissues. Moreover, finding a robust in vitro system that 
can mimic in vivo system will provide great help in differentiating PS cells towards germ 
cells in vitro. The aspect of finding robust in vitro system to culture and mature human germ 
cells as a basis for fertility preservation as well as for better understanding of human gonadal 
cells development and maturation is addressed in papers II, III and IV. 
4.2 EFFECTS OF KSR AND MELATONIN ON GERM CELL DIFFERENTIATION 
IN MURINE TESTICULAR EXPLANT CULTURE. 
In vitro maturation of male germ cells is a complex process and it is still a challenge for 
scientists to mimic the in vivo situation. A promising step was achieved when a testis explant 
culture method using KSR was introduced. On the other hand, the efficiency of this system is 
not optimal yet. In this paper, we aimed to establish this culture condition in two different 
laboratories, to improve the reliability if the culture systems to generate mature germ cells in 
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vitro and to investigate the effects of different concentrations of KSR, melatonin and 
glutamax on germ cells maturation in vitro. 
4.2.1 The impact of the duration of murine testicular tissue explant culture  
We showed here that the duration of murine testicular tissue explant culture had an impact on 
germ cell proliferation and on the efficiency of germ cell maturation up to late/post meiotic 
stage. 
To assess the proliferation of germ cells in culture, the cultured tissues were stained for 
DDX4 as germ cells markers and for KI-67 as a proliferation marker. Thirty five days culture 
samples showed the highest percentage of seminiferous tubules containing cells positively 
stained for DDX4/KI-67 which stained proliferating germ cells, compared to 18 or 56 days 
culture samples. When we compared day 18 and day 56 culture samples, cultured tissues at 
day 18 showed significantly higher proliferation index for germ cells.  
Aiming to assess the degree of germ cells maturation in vitro, the cultured tissues were 
stained for DDX4 as germ cell marker and CREM as post meiotic stage germ cell marker. 
When comparing the number of cells stained positively for DDX4 or DDX4/CREM in the 
seminiferous tubules, tissue cultured for 18 days showed significantly more cells expressing 
DDX4 or DDX4/CREM compared to tissue cultured for 35 days and 56 days.  We observed 
round spermatids in all tissue pieces cultured for 18, 35 and 56 days in vitro. Elongated 
spermatid could be observed in 67% or 60% of all analyzed fragments cultured for 35 and 56 
days, respectively.  
We could show presence of viable spermatogonia population in the whole culture periods by 
positive staining for DAZL, which is a marker for differentiating spermatogonia and early 
spermatocytes.  
4.2.2 The effect of supplementation with melatonin and glutamax  
We demonstrated that supplementation with melatonin and glutamax showed a positive effect 
on germ cell differentiation efficiency. 
To test the effect of glutamax and melatonin on germ cell maturation, testicular tissues were 
cultured for 35 days and the basic medium consisting of DMEM and 10% KSR was 
supplemented with glutamax, melatonin or both. For evaluation, expression of DDX4/KI67, 
DDX4/CREM, and morphologic feature of germ cell subtypes were carried out. Evaluation 
of the number of cells stained positively for DDX4 and DDX4/CREM in the seminiferous 
tubules showed significantly higher number of those cells in culture conditions containing 
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10% KSR and melatonin in contrast to other conditions. Moreover, culture condition with 
10% KSR and glutamax has more DDX4/CREM positive cells when compared with 
condition with 10% KSR only as supplements.  
Cultured germ cells proliferation activity was investigated by evaluating the percentage of 
seminiferous tubules with double positive expression of DDX4 and KI-67. The results 
revealed no significant difference between different groups of culture conditions. 
Morphological evaluation of tissue fragments stained with PAS showed presence of 
spermatocytes and round spermatids in all fragments cultured with 10% KSR and melatonin, 
glutamax, and combination of both. Elongated spermatid could be recognized in 33% of 
tissue fragments when 10% KSR and glutamax added to the culture medium, in 83% of 
fragments when 10% KSR, and melatonin added to the culture medium and in 67% of the 
fragments when10% KSR with both melatonin and glutamax added to the culture medium.  
4.2.3 The effect of supplementation with different concentrations of KSR. 
 Our results revealed that KSR supplementation has a prominent effect on tubule maturation, 
germ cell maturation, and testosterone production with a concentration of at least 10%. 
The results showed that KSR actually has a prominent effect on spermatogenesis in vitro, in a 
dose dependent manner, which proves that KSR is essential for IVM of murine germ cells. 
Testicular tissue fragments were cultured with different concentration of KSR (0%, 0.1%, 
1%, 10%, and 20%) and evaluated by the expression of CREM which indicates germ cell 
maturation beyond the late meiotic/post-meiotic stage. Expression of DDX4 as germ cell 
marker with and without KSR was also investigated. The evaluation revealed significantly 
more CREM-positive cells per tubules in fragments cultured in medium containing 10% 
KSR. No supplementation of KSR or supplementation with 0.1% KSR resulted in absence of 
any detection of CREM-positive cells in any tubules of all the cultured fragments. This 
indicates that there was no germ cell maturation beyond the late meiotic/post-meiotic stage. 
On the other hand, supplementation with 1% KSR resulted in a significant increase in the 
CREM-positive cells per tubules (34 ± 16%) compared to supplementation with 0% or 0.1%.  
The supplementation with 10% and 20% KSR resulted in a significant increase in the CREM 
cells number per tubules compared to supplementation with 0.1% and 1% KSR. However, 
comparing the supplementation with 10% and 20% of KSR revealed no significant 
differences between the two conditions. Evaluation of DDX4 and DDX4/CREM cells per 
tubules revealed the same results of supplementation with 10% and 20% KSR resulted in a 
significant increase compared to supplementation with 0%, 0.1% and 1% of KSR.  
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Morphological evaluation of PAS stained section from different condition of culture showed 
no pachytene spermatocytes could be observed when culture medium supplemented with 0% 
or 0.1% KSR. On the other hand, with supplementation with 10% and 20% of KSR round 
and elongated spermatids could be observed in 83% and 67% of analyzed tissue fragments, 
respectively.  
The initiation of germ cell differentiation and meiosis could be observed when tissue 
fragments were cultured for 3 weeks in the absence of KSR followed by 2 weeks with 
supplementation of 10% KSR, and few round spermatids could be observed in 33% of the 
tissue fragments from this culture setup.  In regard to supplementation with melatonin, a 
significant higher number of DDX4/CREM-positive cells could be observed when melatonin 
was added to the culture medium. 
Testosterone production per week by the tissue fragments cultured in media with different 
concentration of KSR was evaluated.  The results of testosterone production were in line with 
the CREM expression and morphologic evaluation results.  Testosterone levels increased 
with increasing KSR concentration supplemented to the medium of culture. Supplementation 
of 10 % and 20% of KSR to the culture media resulted in significantly higher testosterone 
level after 5 weeks of culture (7 ± 2 and 8 ± 1 ng/mL respectively), compared to 
supplementation with 0%, 0.1% and 1% of KSR (1 ± 0.9, 0.5 ± 0.2 and 1 ± 0.3 ng/mL 
respectively). 
However, supplementation with either 10% or 20% KSR has no significant difference in 
testosterone production. Testosterone production pattern was persistent in all the media 
collected weekly, from the first week till the fifth week of culture.  
4.2.4 Discussion 
In this study, we used the organ explant culture method which has a basic principle of 
culturing the tissue fragments in air-liquid interphase allowing access to oxygen and nutrient 
without disturbing the tissue architecture. To ensure that undifferentiated spermatogonia were 
the most advanced germ cells present in the tissue used for culture, we used 3 dpp mice.  
The reduction in the proliferation around day 56 of culture, as shown in DDX4/KI67 analysis 
and decrease in the number of DDX4 and DDX4/CREM positive cells observed in day 35 
and 56 of culture, indicates that organ culture system might not be stable for the 
differentiation of germ cells beyond 35 days. Our results are in line with what has been 
published previously [271]. 
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In this study, we investigated the effect of glutamax, melatonin and KSR on germ cells 
proliferation and maturation. We previously showed a positive effect of glutamax on rat germ 
cell viability in vitro in our lab [288] and wanted to test if it has the same effect on cultured 
murine germ cells. On the other hand, melatonin was used because it has anti-cytotoxic effect 
by scavenging the reactive oxygen species [289, 290] and previous results showed its positive 
effects on testicular tissues of rats[275] and CD-1 mice[271]. We aimed here to look for 
melatonin effects on cultured murine germ cells. We used a concentration of 10-7 M which is 
shown by other researchers to produce the antioxidant effect [271, 291-293]. 
Sato and his group substituted FBS, which resulted in meiotic arrest when used previously 
[263, 294], with KSR. KSR was introduced to keep stem cells in a pluripotent state and 
preventing differentiation and thus helping in propagation of stem cells in vitro [295]. 
Surprisingly, complete meiosis and production of mature haploid germ cells was achieved 
when 10% KSR was used. When we started this work, the optimal concentration of KSR was 
not reported yet.  
When the number of positive cells for DDX4 and DDX4/CREM per tubules was evaluated, 
we were able to observe a significantly higher number of cells per tubules expressing DDX4 
and DDX4/CREM. When we evaluate the morphology of the cultured sections we could see 
some elongated spermatids when the culture medium supplemented with melatonin. These 
results suggested a supportive effect of melatonin on germ cell differentiation. However, the 
effect of different doses of melatonin should be evaluated by additional experiments.    
Adding KSR to the culture medium with different concentrations and evaluating the cultured 
sections by looking for CREM staining and evaluating the morphology showed dose response 
pattern on germ cell differentiation. The same effect could be seen with tubular maturation in 
terms of formation of the lumen and increase in total cell number per tubule. Germ cell 
differentiation was improved with increasing KSR concentration. However, no added benefit 
on germ cell differentiation could be observed when comparing 20% KSR supplementation 
with 10% KSR supplementation. From these results we could conclude that a concentration 
of 10% KSR is the optimal concentration to use in this setting. 
Evaluation of testosterone produced by the cultured tissue fragments showed the same results 
as germ cell differentiation with different KSR concentration. Testosterone production 
increased with increased KSR concentration supplemented to the culture medium and no 
difference was found between supplementation with 10%KSR and 20% KSR. Since KSR 
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contains lipid rich albumin, we speculate that KSR is responsible for the increase in the 
testosterone production.  
The progression of differentiation of murine germ cells in our culture condition with at least 
10% KSR supplementation was similar to the situation in vivo. However, detailed studies on 
stage specific expression pattern are needed to compare the aspects of spermatogenesis in 
vitro and in vivo.  
4.3 HORMONE PRODUCTION BY HUMAN FIRST TRIMESTER GONADS 
TISSUES CULUTRED IN VITRO  
Study of human gonadal development will help in advancing our knowledge in understanding 
and treating conditions related to fertility. Limited access to human embryo makes it 
challenging to study the early period of gonadal development in vivo. In vitro, study of 
embryological gonads may provide us with clues and information needed for in vitro 
maturation of human germ cells. Organ culture methodologies, as hanging drop and air liquid 
interphase, were used to study human gonadal development; however, the results 
demonstrated a limited progress in germ cell differentiation and mainly focused on testicular 
development and germ cell maturation. Since information about first trimester gonadal tissues 
functionality in vitro cultures is not well studied, we evaluate in this study the functionality of 
human first trimester gonads when cultured in vitro in terms of the ability to produce 
hormones known to have a great impact on human gonadal development. We could 
demonstrate in this study that human first trimester gonads have the potential to produce 
hormones and were functional when cultured in vitro using explant culture conditions. 
Production of hormones from in vitro cultured male and female gonads showing resemblance 
to in vivo normal production of these hormones from gonads at equivalent age. 
4.3.1 Production of testosterone 
In this study, we cultured 27 female and 28 male gonadal tissues at postconceptional age 4.5-
10.5 weeks using air-liquid interphase culture method for 14 days. Media collected at seven 
and 14 days of culture were analyzed for testosterone. The samples were grouped into four 
different groups based on post-conceptional age (4.5-5.5 weeks, 6-7.5 weeks, 8-9.5 weeks 
and 10-10.5 weeks). 
No testosterone was detected above the detection limit (0.03ng/mL) in the media collected 
from female gonads cultures. In contrast, male gonads culture media had more testosterone at 
day 7 and day 14 of culture. A significant difference was observed when testosterone 
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production from male gonads culture of 4.5-5.5 weeks group compared to 10-10.5 weeks 
group at day 7 of culture. 
4.3.2 Production of AMH and inhibin B 
Female cultured gonads did not produce AMH above the detection limit. On the hand, AMH 
was detected in all media samples from cultured male gonads. Analysis of the media 
collected from male gonads culture revealed a significant amount of AMH produced by male 
gonads at age of 8-9.5 weeks compared to male gonads at age of 4.5-5.5 weeks at day seven 
and day 14 of culture. 
Inhibin B produced by cultured male gonads was higher compared to cultured female gonads. 
Inhibin B detected in the media of female gonads culture ranged between 13.5-132 pg/mL 
and there were no significant differences between the age groups. Significantly higher inhibin 
B concentration was detected in the media samples from male gonads cultures in the age 
group 8-9.5 weeks and 10-10.5 weeks compared to those in the age group 4.5-5.5 weeks, at 
day seven and day 14 of culture. 
4.3.3 Discussion 
We did not detect any testosterone in the media collected from female gonads cultures, which 
is shown before that no testosterone is detected in the first trimester ovaries [296]. Higher 
concentrations of testosterone were detected in the media samples from male gonads cultures. 
These results reflect what has been shown before in regard to in vivo situation when higher 
concentration of testosterone was detected in the plasma of male fetuses compared to female 
fetuses and the speculation drawn from this findings that plasma testosterone level is 
predictive of fetal sex [142]. Moreover, previous findings showed that at six weeks post 
conception the testosterone production starts in the human fetus at the same time when 
Leydig cells start to differentiate [143, 296, 297]. 
We did not detect any AMH in the media samples from female gonads cultures. In contrast to 
that, AMH was detected in the media from male gonads cultures as early as four and half 
weeks. Previous studies showed no detection of AMH in the female fetal serum. Moreover, in 
situ hybridization, results showed the absence of AMH transcripts in fetal ovaries [298]. In 
regard to male gonad, it is shown that it is produced by Sertoli cell very early in the fetal life 
from the onset of testicular differentiation [298]. Moreover, AMH detection in the cytoplasm 
of the Sertoli cells was demonstrated as early as six weeks post conception. All these findings 
are in agreement with our in vitro culture results.  
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In our cultures we detected inhibin B in the media from both gonad cultures, male and 
female. However, higher concentration of inhibin was detected from male gonad cultures. 
Previous studies showed that Inhibin B was measured in human chorionic villous extracts 
from male embryos in the first trimester of pregnancy [142]. Moreover, the differences in the 
AMH levels in the male and female sera were demonstrated before and the authors suggested 
to use inhibin B serum concentration as a biochemical marker for fetal sex in the early second 
trimester [142]. These in vivo findings about the first trimester gonads are in line with what 
we have shown in our in vitro culture study. These findings demonstrate that air-liquid 
interphase explant culture method could be a robust method to study human gonadal cells 
development and to provide us with knowledge needed to establish a method for fertility 
preservation by in vitro maturation of human germ cells. 
4.4 ASSESSMENT OF SERTOLI CELLS AND LEYDIG CELLS FUNCTIONS IN 
HUMAN PREPUBERTAL TESTICULAR TISSUES CULTURED IN VITRO 
Increased survival rate of patients treated for malignant and hematological diseases is 
accompanied with increased burden caused by side effects of the treatment regimens used to 
treat such diseases. Prepubertal boys receiving conditioning therapies for hematopoietic stem 
cell transplantation (HSCT), irradiation exposure of the gonads (>=6 Gy), and high doses of 
alkylating agents (>=4000 mg/M2 CED) are at high risk of future infertility. While post 
pubertal boys and men can cryopreserve their sperm for future use to father kids, prepubertal 
boys have some experimental methods with hope to success in the future to restore their 
fertility. These experimental options include cryopreservation of testicular tissue followed by 
transplantation of spermatogonial stem cells, tissue grafting, or in vitro maturation of primary 
SSCs or PS cells. Cryopreservation of testicular tissues is considered as a future option in 
many clinical units worldwide; however, differentiating spermatogonia into functional 
spermatozoa is still a challenge, and proper methodologies for this differentiation are still not 
available. 
Nowadays, in vitro spermatogenesis using testicular explant culture conditions is considered 
a promising option especially after the success reported in maturing murine germ cells in 
vitro as reported by many groups including our group as mentioned in paper II. This 
achievement raised the hope to establish a functional in vitro method for human fertility 
preservation. However, we are not there yet to have a reliable human fertility preservation 
method despite the great achievements in animals. This aspect was addressed in papers III 
and IV, as they aimed to translate using the air-liquid interphase explant culture method to 
culture and mature human germ cells in vitro. 
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In this study, we included patients exposed to high gonadotoxic treatment, divided into four 
groups according to their treatment (Alkylating group, non-alkylating group, sickle cell 
disease patients treated with hydroxyurea, and no-chemotherapy group) were included.  
Testicular tissues were obtained before or during the treatment. For all the groups, testicular 
tissues were cultured for 21 days using explant tissue culture method. Testicular tissues were 
analyzed by germ cell number and markers for Sertoli cell functionality at the day of biopsy. 
Functionality of Sertoli cell and Leydig cell during the course of the in vitro culture was 
analyzed by measurement of Inhibin B, AMH, and testosterone in the conditioned medium. 
4.4.1 Reduction of germ cell number in testicular explant tissue cultures 
Number of germ cells per total seminiferous cord was counted for all four groups at four 
different time points of culture (day 0, 7, 14 and 21 days). At day 0, SCD patients treated 
with HU group and the group receiving alkylating agents showed lower germ cell numbers 
per seminiferous cord. However, this difference in germ cells number at day 0 among the 
groups did not show statistically significant difference due to high variation in the group of 
patients receiving no chemotherapy and the group of patients treated with no alkylating 
agents. On the other hand, we observed that number of germ cells per seminiferous cord 
decreased in all groups to values close to zero at day 21 of culture.  
4.4.2 Similar protein expression of Sertoli cells in vitro cultured testicular 
tissues from four different patient groups 
Aiming to assess Sertoli cell functionality in vitro, we analyzed the protein expression of 
ZO1, AMH, and CK18 for all the groups at day 0, 7, 14, and 21.  
Expression of ZO1 was constant throughout the culture period as evaluated by the percentage 
of positive seminiferous cord for ZO1. Although a decreasing trend in ZO1 expression in the 
group of patients of SCD treated with HU was observed, no statistically significant difference 
was observed among the four groups and in each group at different time points of culture. 
As regards to AMH expression over the period of culture, a decreasing trend was observed 
when the percentage of positive seminiferous cord for AMH expression was evaluated. A 
statistically significant difference in AMH expression reduction was only observed for 
testicular samples from the group of patients not exposed to chemotherapy at day 7, day 14, 
and day 21 when compared to day 0. 
Concerning the expression of CK18, analysis of the percentage of positive seminiferous cords 
showed an increasing trend over the period of culture. Although an increasing trend in CK18 
expression was observed in all the groups over the time of culture, it was only statistically 
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significantly different in tissues from patients not treated with chemotherapy between day 14 
and day 0 as well as day 21 and day 0. 
4.4.3 Impaired somatic cell functions in testicular tissues from SCD patients 
treated with HU 
Testosterone, inhibin B, and AMH concentrations were measured in conditioned medium 
obtained from testicular tissues from different patient groups at day 7, 14 and 21 of culture. 
Analysis of testosterone and inhibin B concentrations showed a trend of increase of both from 
day 7 to day 14 which followed by a decreasing trend from day14 to day 21 in all four 
groups. 
In regards to AMH concentration quantification, when comparing other groups to the group 
of patients not exposed to chemotherapy at different time points of culture, lower 
concentration of AMH was detected in the medium collected from cultured testicular tissue 
of SCD patients treated with HU at day 14 and day 21. 
4.4.4 Discussion: 
Low number of germ cells observed in the testicular tissue from the group of SCD patients 
treated with HU and the group of patients receiving alkylating agents indicates the negative 
impact of the SCD itself as a disease or its treatment using HU and the alkylating agents on 
germ cells in vivo. On the other hand, the reduction of germ cells in all the groups over the 
course of culture to reach a value of zero at day 21 indicate that the current condition of in 
vitro explant culture used to culture the testicular tissues is not optimal. 
We used three markers to assess the maturation of Sertoli cells, ZO-1, AMH and CK-18.  
Immature Sertoli cells have higher expression of CK-18 and AMH compared to mature 
ones[299]. Moreover, ZO1 expression increases with blood testes barrier formation in 
maturing testis and considered as a Sertoli cell maturation marker[300]. 
Analysis of ZO-1 expression in all the four groups showed constant expression over the 
course of culture. AMH expression evaluation revealed a decreasing trend over the culture 
period. While the expression of ZO-1 and AMH go hand in hand with what is expected as 
markers of Sertoli cell maturation, expression of CK-18 does not. We observed an increasing 
trend in CK-18 expression over the period of culture which could indicate de-differentiation 
or malfunction of Sertoli cells in this set up of culture. This de-differentiation or malfunction 
of Sertoli cells could explain the loss of germ cells over the period of culture which 
demonstrate that explant culture conditions did not support testicular tissues in vitro. 
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Our results suggested that the SCD itself and/or the treatment with HU impair the normal 
hormone production of Sertoli and Leydig cells, which most likely occurred in vivo (before 
the testicular biopsy) and was reflected in vitro. More studies will be necessary in order to 
explain whether the cause of this reduced somatic functionality is due to the SCD itself or to 
the treatment with HU. However, the existence of this compromised somatic environment, 
together with the fact that few germ cells were present at the time of biopsy, highlights the 
need of alternative fertility preservation strategies for this group of patients that might not 
rely on the utilization of their biopsied testicular tissue. 
Low levels of testosterone, inhibin B, and AMH at all time points of culture in testicular 
tissues from SCD patients treated with HU propose the negative effects of SCD as a disease 
and/or its treatment on Sertoli cells and Leydig cells functions. Further studies are needed to 
verify the exact cause of the resulted effects on Sertoli cells and Leydig cells; the SCD itself 
or its treatment using HU. Furthermore, more considerations should be taken concerning 
fertility preservation strategies for patients with SCD. Low counts of germ cells at day 0 and 
impaired somatic environment in testicular tissues from patients with SCD might indicate the 
need to look for alternatives as fertility preservation options for such patients other than using 
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5 LIMITATIONS AND FUTURE PERSPECTIVES 
The introduction of human PS cells was a great step in science. Human hES are an 
important tool to study early germ cell development in human. Moreover, human ES cells 
and hiPS cells are a promising future option for infertility treatment. The use of human 
pluripotent stem cell in the reproductive medicine as a therapeutic tool necessitates a 
culture condition that is feeder-free and xeno-free, robust enough to keep these cells 
pluripotent and to minimize the handling effects. Moreover, difficulties in repetition of 
differentiation methods between different laboratories due to lack of such culture condition 
is considered to be a challenge. Remarkable effort has been done and advanced steps were 
made towards achieving such robust culture condition and minimizing the differences in the 
gene composition of these cells resulting from differences in handling and changes in 
laboratories in which these cells being cultured or derived.  
The use of human recombinant laminin LN521 in human embryonic stem cell culture is 
considered a step forward towards generating clinically safe conditions. We studied the 
effect of using LN521, compared to other matrices, as a culture matrix on the 
characteristics of human embryonic stem cells at the gene expression level. We 
demonstrated the positive effect of LN521 in supporting hES cells and maintaining them in 
a normal balanced pluripotency state which could be considered a step towards a robust 
culture condition for hES cells. Homogenization of the gene expression profiles of five 
male hES cell lines initially derived on feeders was observed when these lines were 
cultured on LN521. Having a similar expression profiles might result in more controllable 
and predictable behavior of these different cell lines when used in various differentiation 
protocols which is needed for the use of these cell lines in reproductive medicine. Using 
five hES cell lines in our study strengthens our conclusion and makes it more reliable. 
However, our study spanned for nine passages and it would be of interest to look for the 
effect of LN521 in long term culture. The difference effect we observed between LN521 
and LN121 makes it interesting to study the effect of the difference in alpha chain 
composition of these laminins in producing such differences between the two laminin 
isoforms. More molecular and mechanistic study of impact of this difference is needed in 
the future. 
 
After the positive results shown by Sato and his group in using explant culture method and 
supplementing the medium with KSR resulted in complete spermatogenesis in mice, we 
planned this work as an establishment of the method in our laboratory and our collaborators 
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laboratory. At the beginning of this project, the impact of different concentrations of KSR 
added to the culture medium was not known. We used wild type mice of the same 
transgenic strain that Sato used. We demonstrated the impact of different concentration of 
KSR on germ cell maturation and found that at least 10% of KSR needed to be 
supplemented to the culture medium to get the predominant effect of tubular maturation, 
germ cell maturation, and testosterone production. We showed that supplementation the 
culture medium with glutamax and melatonin resulted in more germ cells achieving post-
meiotic stage of development. However, melatonin seemed to have better effect compared 
to glutamax. More studies are needed to investigate the optimal concentrations needed to 
increase the efficiency of the culture system and to look for the impact of different 
concentrations. This information will help in translating the method and its additive to other 
species to optimize the results obtained using the same culture method. We did not test the 
functionality of the elongated spermatids resulted from the culture because the efficiency of 
the culture and the yield of haploid cells isolation by flow cytometry were very low. 
 
Our understanding of human gonadal cell development, specification and differentiation is 
poor and necessitates more efforts and studies. Since the access to early human embryo is 
out of reach and the number of existing PGCs in the gonads at these stages is small, using 
in vitro model will be a great advancement in our knowledge and understanding. A lot of 
previous and ongoing researches still face a great challenge in achieving a robust in vitro 
method to mature human gonadal cells and tissues in vitro. Our lack of knowledge about 
the exact mechanisms of human gonadal cells specification, characteristic, and main players 
hinder our advancement in achieving robust in vitro methodology and protocols for human 
gonadal development. Moreover, the impact of different molecules in the normal 
development and function of gonads was studied in animal models which made the 
translation to human impractical. Culturing human fetal gonads in vitro will be a great 
advancement in studying the impact of different substances in human gonadal development 
and will help in understanding cells functions in normal development and diseases. We 
demonstrated that cultured fetal gonads in vitro using explant culture method produce 
hormones in resemblance to in vivo situation. This could propose the use of such method to 
elucidate the effect of different substances on fetal gonadal tissue, specifically somatic 
cells. However, our study was limited to somatic cells function analysis. Analysis of germ 
cells maturation will be of great help to understand the development and maturation of 
germ cells. Moreover, more molecular studies are needed to understand the mechanism of 
fetal gonadal somatic cell development, function, and factors controlling them. 
  57 
 
Explant culture conditions showed success in culturing mouse and rat testicular tissues as 
shown before [236, 275]. However, it is not the case when the same methodology used to 
culture human testicular tissues. Our studies here and other researchers as well showed the 
limitation of explant culture conditions to support testicular somatic environment in vitro, 
and thus its failure to maintain germ cells as well. The differences in the timeline 
maturation of somatic cells and germ cells in human and rodents could explain these 
different outcomes of in vitro explant culture of testicular tissues. However, in this study, 
we demonstrate that the explant culture conditions could be used to elucidate the somatic 
environment health and condition in different groups of patients which could be used as a 
tool to assess the testicular tissue biopsies prior to consider the proper fertility preservation 
modality for each patient exposed to hematological and oncological treatments. Moreover, 
the impairment of somatic environment and low germ cells counts in testicular tissues 
obtained from SCD patients treated with HU indicate the negative effect of the SCD itself 
and/or the treatment with HU. However, more studies are needed to elucidate the exact 
cause of such pathology in the testis of this group of patients, as well as to search for the 
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6 CONCLUSION 
 LN521 has a positive effect on maintaining hES initially derived on feeders in a 
normal balanced pluripotent state by homogenizing their gene expression profile. 
This could be a step towards more predictable and controllable behavior of these 
cells when used in various differentiation protocols for possible use of pluripotent 
stem cells in the future applications in regenerative medicine, e.g. their use in 
fertility preservation. 
 LN521 had no effects on expression of genes related to human gonadal cells 
development in hES cells cultured on LN521. This could help in establishing robust 
and reproducible hPS cells culture conditions to enable use of these cells for future 
challenging differentiation protocols such as differentiation towards germ cells. 
 Differentiation of mouse undifferentiated spermatogonia to elongated spermatid 
stage could be achieved in vitro using air-liquid interphase organ culture methods. 
 Supplementation of at least 10% KSR to the mouse testicular tissues in vitro organ 
culture had a prominent effect on tubular maturation, germ cell maturation, and 
testosterone production.  
 Supplementation of glutamax and melatonin to the mouse testicular tissue organ 
culture showed a positive effect on germ cell differentiation efficiency. However, 
more elongated spermatids could be observed when melatonin with 10% KSR was 
used as supplements. 
 First trimester human gonadal cells have the potential to produce hormones known 
to have a significant impact in normal human gonadal development when cultured 
in vitro. 
 Human first trimester gonads cultured in vitro in air-liquid interphase explant 
culture conditions showed the functionality and the ability to produce steroid and 
protein hormones in resemblance to in vivo normal hormone production at 
equivalent developmental stages. 
 Air-liquid interphase explant tissue-culture condition is robust for culturing human 
first trimester gonadal somatic cells in vitro. It can be used to study human gonadal 
development process in vitro. 
 Culturing human first trimester gonads in air-liquid interphase explant tissue-culture 
condition can be used to study the effect of substances suspected to cause hormone 
disturbances at the early period of human gonadal development. 
 Explant culture conditions used to culture human prepubertal testicular tissues in 
vitro are not yet optimal to support germ cell differentiation. 
 Explant culture of human prepubertal testicular tissues in vitro could be used as a 
tool to assess the functionality of the somatic environment of the testicular tissue of 
patients treated for hematological and oncological diseases, ahead of further steps 
towards fertility preservation modalities, such as testicular tissue auto-
transplantation. 
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 Low germ cells count and impaired somatic environment in testicular tissues 
obtained from patients with SCD treated with HU indicate a need for fertility 
preservation strategies which might not rely on the use of patient’s testicular tissue 
biopsy. More studies are needed in this regard to understand the cause of testicular 
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